"","var"
"1","NCT00136084 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and exclusion based on a positive pregnancy test. Negative pregnancy test~Positive pregnancy test"
"2","NCT00136084 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and exclusion based on a positive pregnancy test. Negative pregnancy test~Positive pregnancy test"
"3","NCT03227796 The study explicitly excludes women of childbearing potential, pregnant, or lactating women. It also requires men with female partners of childbearing potential to use effective contraception. Exclusion Criteria:~Women of childbearing potential, or who are pregnant or lactating"
"4","NCT06168734 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Female patients who are pregnant."
"5","NCT06168461 The study explicitly excludes currently pregnant individuals and focuses on women who have had preeclampsia in the past 5 years. The intervention is aimed at treating lasting blood vessel damage after pregnancy. Exclusion criteria:~currently pregnancy"
"6","NCT05798611 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Patients who are pregnant."
"7","NCT00511199 The trial explicitly excludes pregnant and breastfeeding individuals, as well as those who have not had spontaneous menstruation following a delivery or abortion. Before spontaneous menstruation has occurred following a delivery or abortion. Breastfeeding or within 2 months after stopping breastfeeding prior to the start of trial medication."
"8","NCT03767582 Pregnant and breastfeeding women are explicitly excluded from the trial. Woman who are pregnant or breastfeeding."
"9","NCT02510534 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnancy within 3 months"
"10","NCT05083468 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria require women of childbearing potential to have a negative pregnancy test and use contraception. If of childbearing potential, must have a negative pregnancy test at the screening visit (blood test) and before the first study drug administration (Day -1 urine test). They must agree not to attempt to become pregnant, must not be breastfeeding, must not donate ova from signing the consent form until at least 30 days after the last does of study drug, and must agree to: i. Use 2 forms of highly effective contraceptive method at least 2 weeks prior to screening, between signing consent, during the study, and at least 30 days after the last dose of study therapy, OR ii. Use at least one highly effective contraceptive method, plus an additional barrier-method of contraception at least 2 weeks prior to screening, between signing the consent, during the study, and at least 30 days after the last dose of study drug."
"11","NCT02168205 The study explicitly excludes pregnant individuals by requiring participants to be male or postmenopausal women and by implementing a pregnancy prevention risk management plan. Must be male or postmenopausal* women of any race between ≥61 to ≤85 years of age (inclusive) at the time of signing the Informed Consent... Must agree to comply with the conditions described in the counseling document (part of the pomalidomide Pregnancy Prevention Risk Management Plan)."
"12","NCT05129137 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria specify 'non-pregnant female human subjects'. Inclusion Criteria: Male and non-pregnant female human subjects, age 18 - 45 years."
"13","NCT05828953 Pregnant individuals are explicitly excluded from the trial as female participants of childbearing potential must use contraception and have a negative pregnancy test before study entry. Female participants of childbearing potential must agree to use contraception (such as intrauterine device, contraceptive pill, or condom) during the study and for 6 months after the end of the study; must have a negative serum pregnancy test within 7 days before study entry and must not be lactating."
"14","NCT02706834 The study explicitly excludes pregnant individuals by requiring participants to be of non-childbearing potential. Is a healthy male and female (non-child bearing potential) participants."
"15","NCT02204163 The trial explicitly enrolls only pediatric patients with Prader-Willi Syndrome, excluding pregnant individuals. Pediatric patients with PWS confirmed by methylation PCR genetic testing"
"16","NCT01587079 Pregnant and lactating women are explicitly excluded from the trial. The study requires a negative pregnancy test and acceptable contraceptive methods for females of childbearing potential. Women who are pregnant or lactating"
"17","NCT01535053 The trial explicitly excludes pregnant individuals as participants must practice effective contraception and cannot breast-feed during treatment. The study focuses on gestational trophoblastic neoplasia, which involves nonviable pregnancies. Patients must be willing to practice effective contraception for the duration of the study"
"18","NCT02623998 Pregnant individuals are explicitly excluded from the trial as it requires a negative pregnancy test and agreement to use reliable birth control for females with childbearing potential. a negative pregnancy test and an agreement to use a reliable method of birth control for the duration of the trial in all females with childbearing potential"
"19","NCT02376972 Pregnant individuals are explicitly excluded from the trial as participants must have a negative urine pregnancy test and agree to use an adequate method of birth control to avoid pregnancy. Non-pregnant (negative urine pregnancy test at Entry Visit/V1) nor breast-feeding patient"
"20","NCT01863186 Pregnant and lactating individuals are explicitly excluded from the trial. Females of childbearing potential must agree to using birth control methods and must have had documented proof. Female subject who is pregnant or lactating."
"21","NCT04720456 Pregnant individuals are explicitly excluded from the trial. Subjects who are pregnant."
"22","NCT04695080 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria mention pregnancy, planning to father a child, breastfeeding, and the requirement for effective contraception. Pregnancy including planning to father a child or breastfeeding~Unwillingness to use effective contraception throughout the trial period until at least six months after the last administration of IMP."
"23","NCT05979415 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria require female subjects to not be pregnant or breastfeeding and to use effective contraception or commit to abstinence. Female subjects, who are not pregnant or breastfeeding, and one of the following conditions applies: ... Have a negative urine pregnancy test at Screening and Day -1, as verified by the study doctor prior to starting study therapy."
"24","NCT00926575 Pregnant and lactating individuals are explicitly excluded from the trial. Exclusion Criteria:~Pregnancy/lactation"
"25","NCT04983901 Pregnant individuals are explicitly excluded from the trial as participants must agree not to attempt to become pregnant during the study, and if of childbearing potential, must have a negative pregnancy test and use effective contraception. If of childbearing potential (including being < 2 years postmenopausal), is willing to practice sexual abstinence or use an effective dual form of contraception with her partner (eg, 2 barrier methods, barrier method plus hormonal method) during treatment and up 28 days post treatment"
"26","NCT01944800 Pregnant and lactating individuals are explicitly excluded from the trial. The exclusion criteria include a requirement for a negative pregnancy test and agreement to use reliable birth control methods. for women of childbearing potential no negative pregnancy test and no agree to use reliable method of birth control during the study~Pregnancy, giving birth within the last 90 days, or lactation"
"27","NCT01524133 Pregnant females are explicitly excluded from the trial. Exclusion Criteria: Pregnant females"
"28","NCT01225835 The study explicitly excludes pregnant individuals as it focuses on subfertile premenopausal female patients undergoing IVF treatment. The inclusion criteria require participants to be eligible for IVF treatment, which implies they are not currently pregnant. Subfertile premenopausal female patients eligible for in vitro fertilisation (IVF) treatment"
"29","NCT01735370 Pregnant individuals are explicitly excluded from the trial as it requires a negative Beta-hCG pregnancy test and the use of contraceptives for females of childbearing potential. Subjects having negative Beta-hCG Pregnancy test (only for female subjects)."
"30","NCT01233050 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Additionally, women of child-bearing age must have a negative pregnancy test prior to surgery. Exclusion Criteria: Pregnant. If of child-bearing age, patients must have a negative (serum or urine) pregnancy prior to surgery."
"31","NCT01739218 Pregnant or lactating females are explicitly excluded from the trial. Pregnant or lactating females"
"32","NCT00840411 The study explicitly excludes pregnant and lactating females, as well as requires a negative pregnancy test for female participants. Females who are pregnant or lactating."
"33","NCT02564146 Pregnant females and females of childbearing potential unable to perform adequate contraceptive measures or practice complete abstinence from heterosexual intercourse are explicitly excluded from the trial. Pregnant females, breast feeding females or females of childbearing potential unable to perform adequate contraceptive measures or practice complete abstinence from heterosexual intercourse"
"34","NCT01690520 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Pregnant or breastfeeding"
"35","NCT05165485 The study explicitly excludes pregnant and lactating women, and requires women of childbearing potential to have a negative pregnancy test and use highly effective birth control measures. Participant is female and is nonpregnant and nonlactating. A woman of childbearing potential must have a documented negative urine pregnancy test at screening."
"36","NCT01573442 The trial explicitly includes only postmenopausal women, excluding pregnant individuals. Women who are postmenopausal by surgery, radiotherapy or presence of natural amenorrhea ≥ 12 months"
"37","NCT02732314 Pregnant and lactating individuals are explicitly excluded from the trial. Is currently pregnant or lactating or planning to become pregnant in the next 6 months."
"38","NCT01754961 Pregnant and breastfeeding women are explicitly excluded from the trial. Women who are pregnant or breastfeeding."
"39","NCT03250507 The study explicitly excludes pregnant individuals as it involves open abdominal hysterectomies, which are surgical procedures to remove the uterus, making pregnancy impossible. The goal of this study is to evaluate the effectiveness of different formulations of bupivacaine infiltrated into the transversus abdominis plane (TAP) on post-operative pain management after open abdominal hysterectomy."
"40","NCT01433263 Pregnant or lactating women are explicitly excluded from the trial. Additionally, women capable of becoming pregnant must use highly effective contraception and have negative pregnancy test results throughout the study. Pregnant or lactating women. Women capable of becoming pregnant must use highly effective contraception during the study and for 8 weeks after stopping treatment. All female patients must have negative pregnancy test results throughout the study."
"41","NCT01760330 The study is focused on children undergoing palatoplasty, explicitly excluding pregnant individuals by targeting a pediatric population. This project is being used to assess the utility of intravenous acetaminophen in the pediatric population undergoing palate repairs."
"42","NCT00622687 Pregnant individuals were explicitly excluded from the trial as a negative pregnancy test was required for fertile women. For fertile women, a negative pregnancy test was required."
"43","NCT02742441 Pregnant and lactating individuals are explicitly excluded from the trial. The inclusion criteria specify that females must be post-menopausal, surgically sterile, or use an effective method of birth control with a negative urine pregnancy test at the Baseline Visit. Subject is pregnant, lactating, or is planning to become pregnant during the study."
"44","NCT01773798 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Female of childbearing potential who is pregnant, breast-feeding or intend to become pregnant or is not using adequate contraceptive methods (adequate contraceptive measures include sterilisation, hormonal intrauterine devices, oral contraceptives, condom with spermizide, sexual abstinence or vasectomised partner)"
"45","NCT00314340 Pregnant individuals are explicitly excluded from the trial as participants must take a mandatory commercial pregnancy test before any study medication is consumed. Patient is pregnant (as ascertained by a self-report and a mandatory commercial pregnancy test before any study medication is consumed)"
"46","NCT01780259 Pregnant individuals are excluded as participants must agree to a protocol-defined method of contraception. Agree to protocol-defined method of contraception"
"47","NCT06119529 Pregnant and lactating women are explicitly excluded from the trial. Exclusion Criteria: Women who are pregnant and/or lactating"
"48","NCT01589380 Pregnant and breastfeeding women are explicitly excluded from the trial. Female of child-bearing potential who do not use adequate contraception and women who are pregnant or breast-feeding."
"49","NCT01795248 The trial explicitly excludes pregnant and breastfeeding women, as well as those planning to become pregnant within the next 5 years. It also requires safe contraception and a negative pregnancy test. Exclusion Criteria for women with previous GDM: Pregnant or breast feeding women. Women planning to become pregnant within the next 5 years. Safe contraception and negative pregnancy test."
"50","NCT01803867 Pregnant individuals are explicitly excluded from the trial as women of childbearing potential must have a negative serum pregnancy test and must agree to practice adequate contraception or remain abstinent. Women of childbearing potential must have a negative serum pregnancy test at the Screening Visit and Women of childbearing potential and engaged in heterosexual relations must agree to practice adequate contraception for at least 60 days after study dosing."
"51","NCT01803945 The trial explicitly excludes pregnant and breastfeeding women, as well as those with a positive serum pregnancy test. Female patients that are breastfeeding or female patients with a positive serum pregnancy test."
"52","NCT03034967 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria specify that female participants must not be pregnant or breastfeeding and must follow contraceptive guidance. A female participant is eligible to participate if she is not pregnant, not breastfeeding, and at least one of the following conditions applies: Not a woman of childbearing potential (WOCBP) OR A WOCBP who agrees to follow the contraceptive guidance during the treatment period and for at least 60 hours after the last dose of study treatment."
"53","NCT00656227 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Subjects who are pregnant or who become pregnant up to and including Day 0. Subjects must use suitable forms of contraception during at least the first two months of the trial."
"54","NCT00665665 Pregnant individuals are explicitly excluded from the trial as females of childbearing potential must have a negative pregnancy test and must use double barrier contraception. Females who consent to using double barrier method of contraception, are post-menopausal and older than 50 years, or have had total hysterectomy"
"55","NCT00208767 Pregnant individuals are explicitly excluded from the trial as premenopausal females with potential for pregnancy are not eligible. Premenopausal females with potential for pregnancy"
"56","NCT00443729 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Patient is or plans to become pregnant, or is nursing a child"
"57","NCT01098448 Pregnant or nursing individuals are explicitly excluded from the trial. Exclusion Criteria:~pregnant or nursing (if female)"
"58","NCT02269917 Pregnant individuals are excluded from the trial as participants must take contraceptives to participate. Participants must take contraceptives to participate."
"59","NCT02814058 Pregnant and breastfeeding women are explicitly excluded from the trial. Women must use effective contraceptive methods and have a negative BHCG urine test. women cannot be pregnant or in breastfeeding period and should be committed to use an effective contraceptive method during the study"
"60","NCT01658020 Pregnant individuals are explicitly excluded from the trial as female subjects who might be pregnant must do a pregnancy test and results should be negative before randomization. Additionally, subjects who have used single hormone contraception for pregnancy control or have not been more than 1 year after tubal ligation and menopause are excluded. Female subjects who might be pregnant must do pregnancy test and results should be negative before randomization is done. She must receive written informed consent form (NOTE: Subject who has used single hormone contraception for pregnancy control or has not been more than 1 year after Tubule ligation and menopause are excluded from the study)"
"61","NCT03082573 Pregnant individuals are explicitly excluded from the trial. Exclusion Criteria: Pregnancy"
"62","NCT03845023 Pregnant and nursing women are explicitly excluded from the trial. Women who are pregnant or nursing."
"63","NCT03467932 The study explicitly excludes pregnant and breastfeeding individuals as stated in the exclusion criteria. Subject is pregnant or breastfeeding."
"64","NCT02984683 Pregnant or breast-feeding women are explicitly excluded from the trial. Participants with reproductive potential must agree to use accepted and effective method of contraception during the study treatment period and for 6 months following discontinuation of study drug. Pregnant or breast-feeding women. Participants with reproductive potential who do not agree to use accepted and effective method of contraception during the study treatment period and for 6 months following discontinuation of study drug."
"65","NCT01145326 Pregnant individuals are excluded from the trial as it explicitly mentions that women who are currently breastfeeding are excluded. women who are currently breastfeeding"
"66","NCT01721655 The study focuses on preterm infants with chronic lung disease and does not include pregnant individuals. The inclusion criteria specify gestational age < 32 weeks at the time of delivery, indicating the study is for neonates. Inclusion Criteria: Gestational age < 32 weeks at time of delivery"
"67","NCT01882361 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and use medically acceptable contraception if of childbearing age. If female, must have a negative pregnancy test and use of medically acceptable contraception if of childbearing age"
"68","NCT00925587 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The exclusion criteria mention 'Pregnancy or breast feeding, or inadequate contraception'. Pregnancy or breast feeding, or inadequate contraception"
"69","NCT03067194 Pregnant women, nursing mothers, or fertile women who do not practice contraception with appropriate methods are explicitly excluded from the trial. Pregnant women, nursing mothers or Fertile women who not practice contraception with appropriate methods"
"70","NCT02733627 Pregnant individuals are explicitly excluded from the trial as female subjects must be surgically sterilized or postmenopausal to participate. Male subjects, or female subjects who meet any of the following criteria starting from at least 30 days before the first administration of trial medication and until 30 days after trial completion: Surgically sterilised (including hysterectomy) Postmenopausal, defined as at least 1 year of spontaneous amenorrhea (in questionable cases a blood sample with simultaneous levels of Follicle Stimulating Hormone (FSH) above 40 U/L and estradiol below 30 ng/L is confirmatory)"
"71","NCT01063283 Pregnant and lactating individuals are explicitly excluded from the trial. The study requires the use of adequate contraception for women of child-bearing potential. Pregnancy (positive pregnancy test) or lactation."
"72","NCT03424707 Pregnant or lactating women are explicitly excluded from the trial. The study focuses on evaluating the efficacy and safety of a fixed dose combination of Pelubiprofen/Eperisone in patients with acute low back pain. Pregnant or lactating women and appropriate contraceptive *~* Use of hormonal contraceptive, intrauterine devices, spouse sterilization (vasectomy, tubal ligation, etc.), double blockage (use of spermicide in combination with vaginal septum, vaginal sponge or neck cap)"
"73","NCT04175392 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Self-reported pregnant patients"
"74","NCT02635750 Pregnant individuals are excluded as the study requires the use of adequate contraception or other methods to prevent pregnancy. Male subjects, or female subjects who meet any of the following criteria starting from at least 30 days before the first administration of trial medication and until 30 days after trial completion: Use of adequate contraception, e.g. any of the following methods plus condom: intrauterine device (non-hormonal), sexually abstinent, a vasectomised sexual partner (vasectomy at least 1 year prior to enrolment), surgically sterilised (including hysterectomy), postmenopausal, defined as at least 1 year of spontaneous amenorrhea (in questionable cases a blood sample with simultaneous levels of FSH above 40 U/L and estradiol below 30 ng/L is confirmatory)"
"75","NCT05256225 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test if of child-bearing potential. Although the uterus will have been removed in the vast majority of patients, for patients of child-bearing potential: negative urine or serum pregnancy test."
"76","NCT01946386 Pregnant and breastfeeding women are explicitly excluded from the trial. Female subjects who are pregnant or who are breast feeding."
"77","NCT03739268 The study explicitly excludes pregnant individuals by only including men and postmenopausal women. Inclusion Criteria: Men and postmenopausal women"
"78","NCT06220721 The trial explicitly enrolls postpartum individuals within 1 month of giving birth and excludes pre-gestational conditions. Postpartum day 0-3 and prior to discharge"
"79","NCT06216561 Pregnant and nursing individuals are explicitly excluded from the trial. Additionally, women of child-bearing potential must have a negative pregnancy test and use adequate contraception. Women of child-bearing potential with negative pregnancy test prior to undergoing CRS-HIPEC. Participants who are pregnant or nursing."
"80","NCT03262116 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria include a positive pregnancy test, breastfeeding, planning to become pregnant, or being sexually active without contraception. Pregnancy (positive urine HCG), breast feeding, plan to become pregnant in the immediate future, or sexually active without use of contraception Subjects must use acceptable contraception for the two weeks prior to the study, throughout the study and for the two weeks following the study."
"81","NCT03140072 Pregnant individuals are explicitly excluded from the trial as all females must have a negative pregnancy test and must be of non-childbearing potential. All females must have a negative pregnancy test at the screening visit and on admission to the clinical unit, must not be lactating and must be of non-childbearing potential."
"82","NCT05718921 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women."
"83","NCT00807001 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, subjects of childbearing potential must agree to use a consistent form of an acceptable double-barrier method of birth control. Subject is pregnant or breastfeeding"
"84","NCT01089075 Pregnant and lactating individuals are explicitly excluded from the trial. The study does not focus on nonviable pregnancies or postpartum interventions. Exclusion Criteria: Pregnancy and lactation period (during study treatment)"
"85","NCT01251315 Pregnant and nursing females are explicitly excluded from the study. Females who are pregnant or nursing or have a high likelihood of becoming pregnant during the study."
"86","NCT01976208 Pregnant individuals are explicitly excluded from the trial. Participants must agree to use contraception and not be pregnant during the study and for 6 months after. Agreed to be not pregnant, contraception during study and later 6 months. Patients who are currently pregnant or nursing or intend to become pregnant over the course of the study or later 6 months"
"87","NCT05494528 Pregnant subjects are explicitly excluded from the trial. Additionally, female subjects or the spouse of male subjects with child-bearing potential must practice adequate contraception. Pregnant subjects. Female subjects or the spouse of male subjects, with child-bearing potential who are unwilling or unable to practice adequate contraception, defined as vasectomy in men, tubal ligation in women, or use of condoms and spermicides, or birth control pills, or intrauterine devices from 4 weeks prior to Day 1 until 90 days after the last dose of study drug."
"88","NCT01109498 Pregnant individuals are explicitly excluded from the trial as female participants must be of non-child bearing potential or have a negative pregnancy test and not be breastfeeding. Additionally, female subjects must use appropriate contraception, and their spouse must use barrier contraception for the duration of the study. Females must be of non-child bearing potential or with a negative pregnancy test and not breast feeding. Female subjects must use appropriate contraception (if relevant) and their spouse must use barrier contraception for the duration of the study (12 weeks)."
"89","NCT05180773 The study explicitly excludes pregnant individuals and only enrolls women within 5 months postpartum. It does not study nonviable pregnancies or interventions for children. Postpartum women currently breastfeeding and planning to continue."
"90","NCT01057511 Pregnant women are explicitly excluded from the trial as indicated by the exclusion criteria. Pregnant women who indicate hCG positive."
"91","NCT04850144 Pregnant or lactating females and females of childbearing potential not using contraception of acceptable effectiveness are explicitly excluded from the trial. Pregnant or lactating females and females of childbearing potential not using contraception of acceptable effectiveness"
"92","NCT00774787 Pregnant or nursing individuals are explicitly excluded from the trial. Pregnant or nursing"
"93","NCT03565861 Pregnant individuals are excluded as participants must agree to use 2 forms of contraceptive methods for the duration of the study. If of child bearing potential (both men and women) must agree to use 2 forms of contraceptive methods for the duration of study."
"94","NCT06171113 The study explicitly excludes pregnant individuals by stating that only female participants who are not of childbearing potential are eligible. Male participants and female participants who are not of child bearing potential."
"95","NCT02889562 Pregnant individuals are explicitly excluded from the trial as women of childbearing potential must have a negative pregnancy test and agree to use contraception. Women of childbearing potential (WOCBP) must have a negative serum or urine pregnancy test (minimum sensitivity 25 IU/L or equivalent units of HCG) within 24 hours prior to the start of study drug. Women must not be breastfeeding. WOCBP must agree to follow instructions for method(s) of contraception for the duration of treatment with study drug(s)."
"96","NCT01890655 Pregnant individuals are excluded as the study requires two methods of contraception for males and females of reproductive potential. For males and females of reproductive potential, two methods of contraception must be used throughout the study and for 12 weeks after cessation of study medication."
"97","NCT04470024 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the use of contraceptives. Women of childbearing potential must have negative serum/urine pregnancy test <5 days prior to start of study. Males and women of childbearing potential, must agree to take appropriate precautions to avoid pregnancy during treatment and through 180 days after last dose of study treatment."
"98","NCT05216614 Pregnant or breastfeeding mothers are explicitly excluded from the trial. Pregnant or breastfeeding mothers."
"99","NCT05081388 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Pregnancy"
"100","NCT05799495 Pregnant individuals are explicitly excluded from the trial as all fertile participants must agree to use a highly effective method of contraception. All fertile participants must agree to use a highly effective method of contraception."
"101","NCT02767089 The study explicitly excludes pregnant individuals by requiring women to be surgically sterile. Women are to be surgically sterile."
"102","NCT00073008 The trial explicitly excludes pregnant individuals by requiring women of childbearing potential to have a negative serum pregnancy test at screening and to use acceptable methods of birth control. Women of childbearing potential must have a negative serum pregnancy test at screening, and agree to 1 of the following: a Complete abstinence from intercourse from 2 weeks prior to administration of the first dose of GW572016 until 28 days after the final dose of GW572016; or b Consistent and correct use of 1 of the following acceptable methods of birth control."
"103","NCT03737253 The study is focused on women undergoing in vitro fertilization (IVF) or egg donation, which inherently excludes pregnant individuals. The exclusion criteria do not explicitly mention pregnancy, but the nature of the study (IVF) implies exclusion of pregnant individuals. The aim is to be able to predict the hormonal response according to gonadotropin receptor genotype and hormone type used for treatment of women undergoing in vitro fertilization or egg donation."
"104","NCT00329303 Pregnant individuals are excluded as the study requires female subjects to be postmenopausal, surgically incapable of childbearing, or effectively practicing an acceptable method of contraception. Female subjects either postmenopausal for at least one year, surgically incapable of childbearing, or effectively practising an acceptable method of contraception. Subjects agreed to continue using adequate contraception during the study and for 12 weeks after the last dose of CDP870"
"105","NCT02738931 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the exclusion of lactating women. Female subject of non-reproductive potential: is eligible to participate if she is not pregnant (as confirmed by a negative serum or urine human chorionic gonadotrophin [hCG] test), not lactating."
"106","NCT02819141 Pregnant and lactating individuals are explicitly excluded from the trial as indicated by the exclusion criteria. Positive pregnancy test or lactation"
"107","NCT01431339 Pregnant or nursing females are explicitly excluded from the trial. Pregnant or nursing females."
"108","NCT03812198 Pregnant individuals are excluded as female subjects of childbearing potential must use a highly effective form of birth control in conjunction with a barrier method of contraception throughout the trial and for at least 90 days after final follow-up. Female subjects of childbearing potential must be willing to use a highly effective form of birth control in conjunction with a barrier method of contraception throughout the trial and for at least 90 days after final follow-up."
"109","NCT03280095 Pregnant and lactating women are explicitly excluded from the trial. Female volunteers of child-bearing potential must have a negative serum pregnancy test and use contraception. Female volunteers of child-bearing potential and less than one year postmenopausal must have a negative serum pregnancy test and be non-lactating."
"110","NCT02788279 Pregnant, lactating, breastfeeding, or intending to become pregnant during the study are explicitly excluded. Pregnant, lactating, breastfeeding, or intending to become pregnant during the study"
"111","NCT01451606 The study explicitly excludes currently pregnant or lactating women from participation. Currently pregnant or lactating"
"112","NCT03958123 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the use of contraception. If female, have a negative result from a serum pregnancy test at screening and a negative result from a serum or urine pregnancy test on Day -4. If female of childbearing potential, agree to use an effective method of contraception (ie, condom plus diaphragm with spermicide, condom plus spermicide, or nonhormonal intrauterine device) and not become pregnant throughout the study."
"113","NCT02153099 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria specify that female participants must have no childbearing potential, and the exclusion criteria state that females of childbearing potential are not eligible. If female, the participant is of childbearing potential (e.g premenopausal, not sterilized)."
"114","NCT00119587 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of child-bearing potential must be using adequate contraception. Pregnancy (women of child-bearing potential must be using adequate contraception) - Breast feeding"
"115","NCT00777946 Pregnant or nursing women and women of child-bearing potential are explicitly excluded from the trial. Exclusion Criteria: Pregnant or nursing (lactating) women. Women of child-bearing potential."
"116","NCT02675127 Pregnant and nursing women are explicitly excluded from the trial. Additionally, women taking birth control pills are also excluded. Female subjects who were pregnant, nursing or taking birth control pills."
"117","NCT05626621 Pregnant and lactating individuals are explicitly excluded from the trial. Known or suspected pregnancy, or lactation."
"118","NCT00709371 Pregnant or breast-feeding women are explicitly excluded from the trial. Women of child-bearing potential must use acceptable contraception and have a negative pregnancy test. Pregnant or breast-feeding women or planning to become pregnant during the study period or within 30 days of discontinuing study drug"
"119","NCT00048451 Pregnant individuals are excluded as the study requires females to be not of childbearing potential, practicing birth control, and not breastfeeding. If female: Not of childbearing potential, OR Practicing birth control Not breastfeeding"
"120","NCT04412252 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of childbearing potential must use two forms of contraception. A female is eligible if she is not pregnant or breastfeeding. WOCBP must use 2 highly effective forms of contraception."
"121","NCT04349124 The study explicitly enrolls postpartum women with hypertensive disorders of pregnancy and persistent non-severe blood pressure. Pregnant individuals are excluded as the study focuses on the postpartum period. This study is a pilot, open-label, randomized controlled trial of postpartum women with hypertensive disorders pregnancy and persistent non-severe blood pressure."
"122","NCT05761028 Pregnant or lactating women are explicitly excluded from the trial. Fertile women with positive pregnancy test results during screening; Pregnant or lactating women."
"123","NCT04982029 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Currently pregnant"
"124","NCT04855201 Pregnant individuals are explicitly excluded from the trial as female participants must not be pregnant and must follow contraceptive guidance. Additionally, female participants must agree not to breastfeed and not to donate ova during the study period. Female participant is not pregnant and at least 1 of the following conditions apply: Not a woman of childbearing potential (WOCBP) WOCBP who agrees to follow the contraceptive guidance from the time of informed consent through at least 28 days after final IP administration. Female participant must agree not to breastfeed starting at screening and throughout the study period and for 28 days after final IP administration. Female participant must not donate ova starting at first dose of IP and throughout the study period and for 28 days after final IP administration."
"125","NCT05348122 Pregnant or lactating females are explicitly excluded from the trial. Pregnant or lactating female;"
"126","NCT03588026 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Planned or actual pregnancy or breast feeding (females)"
"127","NCT00624559 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: pregnant"
"128","NCT04269408 Pregnant or lactating women are explicitly excluded from the trial. Additionally, female patients of child-bearing potential must have a negative pregnancy test and use adequate birth control. Pregnant or Lactating Women."
"129","NCT00603434 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and agree to use birth control. If female, have a negative pregnancy test and agree to use one of the following methods of birth control, or be postmenopausal, have had a hysterectomy or have been sterilized."
"130","NCT00761995 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must use contraception, have a negative pregnancy test, and be non-lactating. Must have a negative pregnancy test. Must be non-lactating. Pregnant and lactating females"
"131","NCT03637400 Pregnant or lactating individuals are explicitly excluded from the trial. Women of childbearing potential must have a negative pregnancy test and agree to use birth control. Pregnant or lactating, or intending to become pregnant within 3 months after screening Women of childbearing potential must have a negative urine or serum pregnancy test result within 1 day prior to initiation of study drug."
"132","NCT03859986 Pregnant individuals are explicitly excluded from the trial as female subjects of childbearing potential must have a negative pregnancy test and agree to use contraception. Additionally, females who are breastfeeding, pregnant, or planning to become pregnant during the study are excluded. Female subject of childbearing potential involved in any sexual intercourse that could lead to her pregnancy, must have a negative serum pregnancy test at Visit 1, a negative urine pregnancy test at Visit 2 (baseline) and agree to use an approved highly effective contraceptive method for the entire study and up to 4 weeks following the final dose of study medication unless they are surgically sterile (hysterectomy, bilateral oophorectomy, or bilateral salpingectomy) or in menopausal state for at least one year prior to screening (Visit 1)... Subject is a female who is breastfeeding, pregnant, or who is planning to become pregnant during the study."
"133","NCT05857215 Pregnant and lactating individuals are explicitly excluded from the trial. The study requires a negative pregnancy test for female participants. Females of childbearing potential including those who were pregnant or lactating (all female subjects must have had a negative highly sensitive urine and serum pregnancy test)."
"134","NCT01181934 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of childbearing potential must have a negative pregnancy test and use contraception. Female volunteers who are pregnant or breastfeeding"
"135","NCT00034047 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Exclusion Criteria:~Pregnancy or breast feeding"
"136","NCT00541697 Pregnant or lactating individuals are explicitly excluded from the trial. Pregnant or lactating"
"137","NCT04372940 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: pregnancy surgery"
"138","NCT03789552 Pregnant individuals are explicitly excluded from the trial as female patients of child-bearing potential must have negative pregnancy tests at screening and randomization, and must use appropriate birth control. Female patients of child-bearing potential must have negative pregnancy tests at screening visit [Day -21, quantitative serum human chorionic gonadotropin (β-hCG test)] and randomization visit (Day 1, urine pregnancy test)."
"139","NCT04385563 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and use contraception. Female with childbearing potential: negative pregnancy test within 7 days before the first administration of the investigational drug; patients are not breastfeeding; Contraception use must continue for the duration of study treatment and for at least 6 months after the last dose of study treatment."
"140","NCT01276327 Pregnant individuals are excluded as the study involves healthy male and female subjects, and pregnancy is not mentioned in the inclusion criteria. Healthy male and female subjects"
"141","NCT02466074 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the need for effective birth control. Positive pregnancy test or inability or unwillingness to use effective means of birth control."
"142","NCT03987620 Pregnant individuals are excluded from the trial as the study requires participants to be postmenarchal females with a diagnosis of symptomatic AVVC. The exclusion criteria do not explicitly mention pregnancy, but the requirement for postmenarchal females implies exclusion of pregnant individuals. Subject is a postmenarchal female subject 12 years and older"
"143","NCT02003625 Pregnant or lactating individuals are explicitly excluded from the trial. Exclusion Criteria: Pregnancy or lactation"
"144","NCT01663532 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The exclusion criteria specify that sexually active females of childbearing potential must practice birth control or remain abstinent, and females who are breastfeeding or have a positive pregnancy test are excluded. Females who are breast-feeding and/or who have a positive pregnancy test result prior to receiving IMP in this trial."
"145","NCT02275546 The study explicitly excludes pregnant individuals as participants must be non-pregnant and pre-menopausal. Additionally, participants must not be within 2 months of their last pregnancy outcome. is pregnant or within 2 months of last pregnancy outcome (delivery, spontaneous or induced abortion, medical or surgical management of ectopic pregnancy)."
"146","NCT03585504 The study explicitly excludes pregnant individuals as it focuses on postpartum adolescents and involves the insertion of a contraceptive implant. The exclusion criteria also mention breastfeeding women, which implies that the study does not include pregnant individuals. Exclusion Criteria:~women who are breastfeeding"
"147","NCT00903344 The study explicitly excludes pregnant individuals as it only enrolls fully lactating mothers within 1 month after delivery. Inclusion Criteria:~Fully lactating mothers age 18 and up~Within 1 month after delivery~Plan to breast feed for at least 6 months"
"148","NCT05877638 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Current pregnancy"
"149","NCT05740280 The study explicitly excludes pregnant and lactating females, and only includes females of nonchildbearing potential. Females will not be pregnant or lactating."
"150","NCT00839293 Pregnant or breastfeeding females are explicitly excluded from the trial. Exclusion Criteria:~Females who are pregnant or breast-feeding"
"151","NCT00006734 Pregnant individuals are explicitly excluded from the trial. The study requires fertile patients to use effective contraception. Not pregnant or nursing. Fertile patients must use effective contraception."
"152","NCT04732169 Pregnant and lactating women are explicitly excluded from the trial. Women of reproductive potential must have a negative urine pregnancy test at screening. For females: no current pregnancy or lactation (women of reproductive potential must have a negative urine pregnancy test at screening)."
"153","NCT00166543 The trial explicitly includes only postmenopausal females, which excludes pregnant individuals. Inclusion Criteria: Postmenopausal females"
"154","NCT02939326 Pregnant and lactating women are explicitly excluded from the trial. Women of childbearing potential must use dual methods of contraception and must not be pregnant, lactating, or planning to become pregnant during the study. Women of child bearing potential must not be pregnant, lactating, or planning to become pregnant during the study."
"155","NCT00862225 Pregnant and lactating individuals are explicitly excluded from the trial. Women of childbearing potential must use a highly effective method of birth control. Pregnancy or lactation"
"156","NCT02367183 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Additionally, females of childbearing potential must have a negative pregnancy test and use contraception. Pregnant or breastfeeding."
"157","NCT04892641 The trial explicitly excludes pregnant or lactating individuals and requires women of childbearing potential to use contraception and have a negative pregnancy test. Exclusion Criteria:~Pregnant or lactating at Screening or planning to become pregnant (self or partner) at any time during the study, including the F/U period."
"158","NCT00218218 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Exclusion Criteria:~Pregnant or breastfeeding"
"159","NCT02294734 Pregnant individuals are explicitly excluded from the trial as the inclusion criteria require a negative pregnancy test and the use of contraception for females of reproductive potential. Female subject: is eligible to participate if she is not pregnant (as confirmed by a negative urine human chorionic gonadotrophin [hCG] test), not lactating, and at least one of the following conditions applies: Non-reproductive potential defined as... Reproductive potential and agrees to follow one of the options listed below in the GSK Modified List of Highly Effective Methods for Avoiding Pregnancy in Females of Reproductive Potential (FRP) requirements from 30 days prior to the first dose of study medication and until completion of the follow-up visit."
"160","NCT00399711 Pregnant individuals are explicitly excluded from the trial as indicated by the exclusion criteria mentioning 'Pregnancy diabetes'. Exclusion Criteria: Pregnancy diabetes"
"161","NCT02350725 The study explicitly excludes pregnant individuals by requiring female subjects to be at least 2 years post-menopausal. Female subjects must be at least 2 years post-menopausal"
"162","NCT01213407 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the need for participants to use birth control. Positive pregnancy test or breast-feeding.~Patients unwilling to perform a save method of birth control."
"163","NCT00376714 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the exclusion of subjects with a positive pregnancy test. The subject has a positive pregnancy test."
"164","NCT01012895 Pregnant individuals are explicitly excluded from the trial. Pregnant chronic hepatitis c"
"165","NCT02697136 The study explicitly excludes females of childbearing potential, indicating that pregnant individuals are not included. Main Exclusion Criteria: Females of childbearing potential"
"166","NCT02285920 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnancy, anticipated pregnancy, or breastfeeding"
"167","NCT04221360 The study explicitly excludes pregnant or lactating women and requires females to be menopausal or surgically infertile. Males must use contraceptives. Pregnant or lactating women~Females must be menopause or surgical infertility~Males who have consented to the use of appropriate pregnancy contraceptive methods up to 28 days after the last investigational product and not to provide sperm"
"168","NCT00966953 Pregnant or nursing women are explicitly excluded from the trial. Pregnant or nursing women."
"169","NCT02168309 The study explicitly enrolls postpartum individuals and does not include pregnant individuals. The focus is on managing severe postpartum hypertension. Postpartum~Persistent postpartum blood pressures ≥ 160/105 on two or more occasions"
"170","NCT03079921 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the use of effective contraceptive measures. For female participants of child-bearing potential: Positive pregnancy test, presently breast-feeding, or unwillingness to use effective contraceptive measures for the duration of study participation."
"171","NCT04385290 Pregnant or nursing women are explicitly excluded from the trial. Additionally, women of child-bearing potential must have a negative serum pregnancy test and use contraception. Pregnant or nursing (lactating) women~Women of child-bearing potential, defined as all women physiologically capable of becoming pregnant, unless they fulfill at least one of the following criteria:~Post-menopausal (12 months of natural amenorrhea or 6 months of amenorrhea with serum follicule stimulating hormone > 40 U/ml)~Postoperative (i.e. 6 weeks) after bilateral ovariectomy with or without hysterectomy~Women of childbearing potential must have a negative serum pregnancy test performed within 7 days before the first dose of study drug~Continuous and correct application of a contraception method with a Pearl Index of < 1% (e.g. implants, depots, oral contraceptives, intrauterine device) from initial study drug administration until at least 7 months after the last dose of gemtuzumab ozogamicin and at least 4 months after the last dose of midostaurin, whichever period is longer. A hormonal contraception method must always be combined with a barrier method (e.g. condom)~Sexual abstinence~Vasectomy of the sexual partner~Sexually active males unless they use a condom during intercourse while taking the drug during treatment, and for at least 4 months after stopping treatment and should not father a child in this period. A condom is required to be used also by vasectomized men as well as during intercourse with a male partner in order to prevent delivery of the drug via semen"
"172","NCT01006018 The trial explicitly excludes women of child-bearing age who are pregnant, desire to become pregnant, are breastfeeding, or who refuse to take the recommended birth control measures. Women of child-bearing age who are pregnant, desire to become pregnant, are breastfeeding, or who refuse to take the recommended birth control measures"
"173","NCT00932152 The trial explicitly excludes pregnant or breastfeeding individuals as stated in the exclusion criteria. Pregnant or breast feeding."
"174","NCT00099489 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, female subjects must practice effective contraception and cannot consider becoming pregnant during the study. Female subjects who are currently pregnant or breast-feeding."
"175","NCT02904954 Pregnant individuals are explicitly excluded from the trial as evidenced by the requirement for a negative pregnancy test and the exclusion of pregnant or breastfeeding women. Female patients who are pregnant or breastfeeding or male or female patients of reproductive potential who are not willing to employ effective birth control from screening to 90 days after the last dose of durvalumab monotherapy."
"176","NCT06008106 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative serum pregnancy test for premenopausal female patients. Serum pregnancy test results are positive for premenopausal female patients;"
"177","NCT01147627 Pregnant individuals are excluded as female patients of reproductive age are required to practice a reliable method of birth control throughout the study. female patients of reproductive age should practice a reliable method of birth control throughout the study"
"178","NCT00258076 The study explicitly excludes pregnant individuals as it requires negative pregnancy tests and specifies that participants must not be currently pregnant or breastfeeding. Subjects who are not pregnant (as demonstrated by negative pregnancy tests at screening and before admission for each treatment period) and who have completed their last term pregnancy at least 60 days before the admission visit"
"179","NCT02955394 The trial explicitly excludes pre- or peri-menopausal women unless they have concurrent ovarian suppression, which effectively excludes pregnant individuals. Postmenopausal, or if pre- or peri- menopausal, then will need to have concurrent ovarian suppression."
"180","NCT00006004 Pregnant and nursing individuals are explicitly excluded from the trial. Fertile patients must use effective contraception. Not pregnant or nursing. Fertile patients must use effective contraception."
"181","NCT00002548 Pregnant individuals are explicitly excluded from the trial. The study requires fertile patients to use effective contraception. Not pregnant or nursing. Fertile patients must use effective contraception."
"182","NCT04160000 The trial explicitly excludes pregnant or nursing lactating mothers and women of childbearing potential who are not on effective contraceptive therapy. Pregnant or nursing lactating mothers or women of childbearing potential who are not on effective contraceptive therapy"
"183","NCT00995150 The study explicitly excludes currently pregnant individuals, those who were pregnant within 4 weeks prior to study entry, and those planning pregnancy within 24 months of study entry. It also excludes currently breastfeeding individuals. Exclusion Criteria:~Currently pregnant, pregnant within 4 weeks prior to study entry or planning pregnancy within 24 months of study entry~Currently breastfeeding"
"184","NCT00299923 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, all fertile males and females must use two reliable forms of effective contraception during treatment and 6 months post-treatment. Ongoing pregnancy or breast feeding. All fertile males and females must use two reliable forms of effective contraception (combined) during treatment with study drugs and 6 months post treatment."
"185","NCT00754065 The study explicitly excludes pregnant and lactating individuals, as well as those who have had less than three cycles since delivery, abortion, or lactation before the start of treatment. The study focuses on comparing oral contraceptives in healthy female volunteers requesting contraception. Exclusion Criteria: Pregnancy or lactation (less than three cycles since delivery, abortion, or lactation before start of treatment)"
"186","NCT03189719 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Female participants of childbearing potential must have a negative pregnancy test and use contraception. Is pregnant or breastfeeding, or expecting to conceive or father children within the projected duration of the study, starting with the screening visit through 120 days after the last dose of study medication and up to 180 days after last dose of cisplatin"
"187","NCT00019682 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Patients who are pregnant"
"188","NCT02323451 Pregnant or lactating females are explicitly excluded from the trial. Pregnant or lactating females."
"189","NCT03011645 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of childbearing potential must undergo pregnancy testing and are excluded if they are not willing to receive information on positive pregnancy test results. Women who are known to be pregnant, intend to become pregnant, or breast-feeding will be excluded. Women who are of child bearing potential (under age 55) will be informed that they will need to have their urine tested for pregnancy and that they should not participate in the research if they are not willing to have the Investigators provide them with information on positive pregnancy test results."
"190","NCT03361865 Pregnant individuals are explicitly excluded from the trial as participants must have adequate organ function and meet other health criteria that would not be applicable to pregnant individuals. Adequate organ function per protocol-defined criteria."
"191","NCT03242018 Pregnant individuals are explicitly excluded from the trial as women of childbearing potential must use highly effective birth control methods and be tested for pregnancy. Women of childbearing potential (WOCBP) not willing to use highly effective method(s) of birth control during the study treatment period and the follow-up period, or who are unwilling or unable to be tested for pregnancy during the study."
"192","NCT02753426 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: pregnancy;"
"193","NCT03440021 Pregnant and breastfeeding individuals are explicitly excluded from the trial. pregnancy or breast-feeding status"
"194","NCT00547898 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Exclusion Criteria: Pregnancy or breast-feeding"
"195","NCT05641298 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must have a negative pregnancy test and agree to use a highly effective method of contraception during the study and 30 days after the last dose. Participants must have a negative pregnancy test and agree to use a highly effective method of contraception during the study and 30 days after last dose. Female participant who is pregnant or lactating."
"196","NCT01602315 Pregnant or nursing (lactating) women were explicitly excluded from the trial. Pregnant or nursing (lactating) women"
"197","NCT00583700 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant"
"198","NCT03126149 The trial explicitly excludes pregnant individuals by requiring female participants to be of non-childbearing potential. Healthy males and female of non-childbearing potential"
"199","NCT02680782 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and agree to use effective contraceptive methods. For women of childbearing potential, (a) agree to use effective contraceptive methods from screening, through the study, and for at least 4 weeks after the last dose of study drug; and (b) have a negative pregnancy test (serum or urine) at screening and on Day -1 prior to each Dosing period."
"200","NCT00133848 Pregnant individuals are explicitly excluded from the trial as women who could bear children must have a negative urine pregnancy test and agree to either abstain from sexual intercourse or use specific effective contraceptive measures. Women who could bear children must have a negative urine pregnancy test and agree to either abstain from sexual intercourse or the use of specific effective contraceptive measures."
"201","NCT00436579 Pregnant and nursing individuals are explicitly excluded from the trial. Participants must have a negative pregnancy test and use effective contraception. Not pregnant or nursing~Negative pregnancy test~Fertile patients must use effective contraception"
"202","NCT00649896 The study explicitly excludes pregnant individuals as it only includes postmenopausal women aged 40-69 years. Absence of menses for one year for postmenopausal subjects, or at least 6 weeks for oophorectomized subjects."
"203","NCT05452525 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Those who are pregnant or breastfeeding"
"204","NCT06212648 Pregnant or lactating women are explicitly excluded from the trial. Additionally, women and men of childbearing potential must agree to use effective contraceptive methods during the trial and for 4 weeks after the last investigational drug administration. Pregnant or lactating women~Women and men of childbearing potential who do not agree to use a combination of effective or medically acceptable contraceptive methods* for the duration of the clinical trial and 4 weeks after administration of the last investigational drug"
"205","NCT04924114 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Is pregnant or nursing or is planning to become pregnant during the study."
"206","NCT03049189 Pregnant or breast-feeding women are explicitly excluded from the trial. Pregnant or breast-feeding women"
"207","NCT00826202 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. females who are of childbearing potential but are not taking adequate contraceptive precautions or who are pregnant or breast feeding"
"208","NCT00474916 The study explicitly excludes pregnant individuals by requiring females to be sterile or post-menopausal. Females must be sterile or post-menopausal"
"209","NCT04240535 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, females of childbearing potential must use effective birth control and take a urine pregnancy test. Male or non-pregnant, non-breastfeeding females. If the subject is a female of childbearing potential, she agrees to use an acceptable form of effective birth control for the duration of the study and is willing to take a urine pregnancy test at the screening/enrollment visit and prior to treatment."
"210","NCT03340597 Pregnant and lactating women are explicitly excluded from the trial. Additionally, female subjects of childbearing potential must agree to use appropriate contraception. Female subjects who are pregnant or lactating."
"211","NCT02819921 Pregnant and breastfeeding women are explicitly excluded from the trial. Women who is pregnant or breast feeding, or who has a history of seizure disorder or hepatic or renal insufficiency"
"212","NCT00120302 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, females of childbearing potential must practice contraception and have a negative pregnancy test to participate. At baseline and throughout the study, females of childbearing potential: Who are pregnant or breast-feeding. Who are menstruating, capable of becoming pregnant, and not practicing a medically approved method of contraception during and up to at least 4 weeks after the end of study treatment. A negative pregnancy test (urine) for all females of childbearing potential is required at the screening visit."
"213","NCT00057941 The trial explicitly includes only postmenopausal women, which excludes pregnant individuals. The inclusion criteria specify that all patients must be postmenopausal females. All patients must be postmenopausal females defined by: Prior bilateral oophorectomy or bilateral ovarian irradiation; No menstrual period for 12 months or longer."
"214","NCT02190604 Pregnant or nursing (lactating) women are explicitly excluded from the trial. Additionally, women of child-bearing potential must use highly effective contraception. Pregnant or nursing (lactating) women. Women of child-bearing potential, UNLESS they are using highly effective contraception."
"215","NCT00127985 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnancy."
"216","NCT00132743 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Patients who are pregnant, planning to become pregnant, or lactating"
"217","NCT05816252 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Is pregnant or breastfeeding, or expecting to conceive or father children within the projected duration of the study;"
"218","NCT01600703 Pregnant individuals are explicitly excluded from the trial as a pregnancy test is required and those who test positive will be excluded. A pregnancy test will be performed 1 to 3 days prior to each study in all female subjects. Those who test positive for pregnancy will be excluded."
"219","NCT02515799 The study explicitly excludes pregnant individuals by requiring women of childbearing potential to use a highly effective form of birth control. Women of childbearing potential (WOCBP) must use a highly effective form of birth control (confirmed by the Investigator)."
"220","NCT02418468 Pregnant or nursing women were explicitly excluded from the trial. Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test."
"221","NCT00469690 Pregnant and nursing women are explicitly excluded from the trial. Female patients who are pregnant, nursing an infant or planning a pregnancy"
"222","NCT05983250 Pregnant and lactating individuals are explicitly excluded from the trial. Female subjects of childbearing potential must have a negative pregnancy test and use highly effective birth control methods. Female subjects of childbearing potential must have a negative urine pregnancy test result at the Screening Visit and a negative urine pregnancy test and must not be pregnant, lactating, or planning a pregnancy from the Screening Visit to 7 months after the last dose of study drug."
"223","NCT02508207 Pregnant or nursing females are explicitly excluded from the trial. Pregnant or nursing females"
"224","NCT01312844 Pregnant individuals are explicitly excluded from the trial as female subjects must be postmenopausal, surgically sterile, or using contraceptives and have a negative pregnancy test. Female subjects must be postmenopausal, surgically sterile, or, if of child-bearing age, using double-barrier contraceptive method or prescription oral contraceptives (e.g. estrogen-progestin combinations), contraceptive implants (e.g. NorplantTM, DepoProveraTM, or transdermally delivered contraceptives (Ortho EvraTM) before entry and throughout the study; and have a negative urine b-HCG pregnancy test at screening."
"225","NCT01770431 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women;"
"226","NCT02662023 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria:~pregnancy;"
"227","NCT04333537 Pregnant and breast-feeding mothers are explicitly excluded from the trial. Pregnancy and breast-feeding mothers"
"228","NCT04857957 Pregnant and lactating individuals are explicitly excluded from the trial. Additionally, females must not be currently pregnant and must use an adequate method of birth control. Is pregnant, lactating, or planning a pregnancy during the study."
"229","NCT00884832 The study explicitly excludes pregnant or nursing women from participation. Pregnant or nursing women"
"230","NCT00647738 The study explicitly includes only healthy male volunteers aged 18-55 years, thus excluding pregnant individuals. Males aged from 18 to 55 years with a body mass index (BMI) greater than or equal to 19 and below 30"
"231","NCT02803749 Pregnant and lactating women are explicitly excluded from the trial. Lactating or pregnant woman"
"232","NCT01593722 Pregnant and breastfeeding women are explicitly excluded from the trial. The study involves administration of medications contraindicated in pregnancy. Eligibility: - Individuals who live in 4 villages in Cameroon where Loa loa infection is known to exist, who are between 20 and 60 years of age, not pregnant or breastfeeding and have a low level of Loa loa parasites in the blood, but are otherwise healthy. EXCLUSION CRITERIA (SCREENING): Known to be pregnant (by history) or breastfeeding. EXCLUSION CRITERIA (INTERVENTIONAL STUDY): Pregnancy (by serum or urine beta-HCG) or breastfeeding. EXCLUSION OF CHILDREN AND PREGNANT WOMEN: Pregnant women and children (the age of consent in Cameroon is 20 years of age) will be excluded from this study since it involves administration of medications contraindicated in pregnancy and more than minimal risk with no prospect of direct benefit, respectively."
"233","NCT04790305 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women, and those who planning a pregnancy during the study period."
"234","NCT04401059 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women."
"235","NCT02943213 Pregnant and lactating individuals are explicitly excluded from the trial. The inclusion criteria require a negative pregnancy test and the exclusion criteria state that female subjects who are pregnant or breastfeeding are excluded. Female subjects that are pregnant (positive pregnancy test) or breastfeeding."
"236","NCT00777127 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, women of childbearing potential must use a highly effective method of birth control. Pregnancy, breast-feeding or planned pregnancy during the study. Women of child bearing potential not using a highly effective method of birth control defined as those which result in a low failure rate (i.e. <1% per year) when used consistently and correctly such as implants, injectables, combined oral contraceptives, hormonal IUDs, tubal ligation or vasectomised partner."
"237","NCT02324972 Pregnant and breastfeeding women are explicitly excluded from the trial. Female subject who is pregnant or breast-feeding"
"238","NCT00166257 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnancy"
"239","NCT02453789 Pregnant or breast-feeding women are explicitly excluded from the trial. A negative urine pregnancy test must be demonstrated in females of child-bearing potential at Screening. Pregnant or breast-feeding women. A negative urine pregnancy test must be demonstrated in females of child-bearing potential at Screening."
"240","NCT05743244 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must have a negative pregnancy test and use highly-effective contraceptive methods. Be currently pregnant or lactating or anticipate becoming pregnant during the study"
"241","NCT02278562 Pregnant individuals are explicitly excluded from the trial. Exclusion Criteria: Pregnancy;"
"242","NCT00674310 Pregnant individuals are excluded as the study requires participants to have no clinically significant abnormal findings on physical examination, medical history, or clinical laboratory results during screening, which typically includes a negative pregnancy test. No clinically significant abnormal finding on the physical examination, medical history, or clinical laboratory results during screening"
"243","NCT02917291 Pregnant women and women of childbearing age not using contraception are explicitly excluded from the trial. Pregnant women or women of childbearing age who are not using an appropriate method of contraception and, moreover, are not willing to continue to use it for the duration of the trial."
"244","NCT00171132 The trial explicitly enrolls postmenopausal women, which excludes pregnant individuals. The purpose of the study is to show that valsartan compared to atenolol has favorable effects on exercise capacity, quality of life, diastolic function and elevated blood pressure in hypertensive postmenopausal overweight women with impaired exercise tolerance despite normal left ventricular ejection fraction (LVEF)."
"245","NCT04229615 The trial explicitly excludes pregnant individuals as it involves advanced ovarian cancer treatment and requires participants to have completed a platinum-based chemotherapy regimen. Exclusion Criteria: Patients who have received other study drug treatment within 4 weeks prior to the first administration(< 5 elimination half-lives of the study drug molecular targeted anti-cancer drugs)."
"246","NCT00181077 The study explicitly excludes pregnant individuals as it requires women to have delivered their infants prior to initiating therapy. Women must have delivered their infant(s) prior to initiating therapy"
"247","NCT00405392 The study explicitly enrolls postmenopausal women, which excludes pregnant individuals. This is a randomized open label, multi-centre study for Korean women with postmenopausal osteoporosis."
"248","NCT02439359 Pregnant and lactating individuals are explicitly excluded from the trial. The inclusion criteria specify that females of childbearing potential must be non-pregnant and non-lactating, and must use contraception. Be a healthy non-pregnant, non-lactating female of any race or ethnicity of childbearing potential between 18 and 55 years of age,~Contraception in use for at least 60 days prior to the Screening visit"
"249","NCT04545541 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria state that females aged 18-49 years are excluded unless there is documented menopause or hysterectomy or a pregnancy test was performed and is negative. Pregnant or might be pregnant. Females aged 18-49 years are excluded unless there is documented menopause or hysterectomy or a pregnancy test was performed and is negative."
"250","NCT03487198 Pregnant and lactating individuals are explicitly excluded from the trial. The exclusion criteria specify that females who are breast-feeding or lactating and those who have a positive pregnancy test result prior to screening or randomization are not eligible to participate. Females who are breast-feeding or lactating and who have a positive pregnancy test result (Urine or serum test) prior to screening or randomization (within 72 hours)."
"251","NCT03482440 The study explicitly excludes current pregnancy and focuses on postpartum women who have delivered within two years. It aims to investigate cardiovascular disease risk in women who have had preeclampsia. Exclusion Criteria:~current pregnancy"
"252","NCT02873936 Pregnant individuals are explicitly excluded from the trial. Key Exclusion Criteria:~Previous treatment with any janus kinase (JAK) inhibitor~NOTE: Other protocol Inclusion/ Exclusion criteria may apply."
"253","NCT05533411 The trial explicitly excludes women of childbearing potential and lactating women, indicating that pregnant individuals are excluded. Exclusion Criteria: Are lactating. Are women of childbearing potential."
"254","NCT04307953 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, women of child-bearing potential must use contraception, and male participants must use contraception if they have a pregnant partner. Women who are pregnant or breast-feeding (from the time 3 months prior to 4 weeks after completion of participation in the study)"
"255","NCT02673593 The study explicitly excludes pregnant individuals by requiring participants to be non-smokers and have a negative urine cotinine test, which implies a requirement for non-pregnancy. Subject is male or female and is aged between 18 and 45 years inclusive. Subject is a non-smoker, has been a non-smoker for 3 months prior to screening and has a negative urine cotinine test at screening."
"256","NCT04258397 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria mention pregnancy, planning to become pregnant, or currently breast-feeding, and require women under 55 to have a reliable method of birth control or have no menses in the preceding 2 years. Pregnancy, planning to become pregnant, or currently breast-feeding; women under 55 will need to either have a reliable method of birth control (IUD {intrauterine device}, oral contraceptive pills {OCPs}) or have no menses in the preceding 2 years."
"257","NCT00461305 The study explicitly excludes pregnant individuals as it involves the administration of contraceptives (Drospirenone/Ethinylestradiol) and requires participants to have a normal menstrual cycle. Exclusion Criteria: Patients with undiagnosed abnormal vaginal bleeding"
"258","NCT01999400 Pregnant or lactating females are explicitly excluded from the trial. Pregnant or lactating females."
"259","NCT00847886 Pregnant and nursing women are explicitly excluded from the trial. Participants must practice contraception, indicating exclusion of pregnant individuals. Women who are pregnant or nursing"
"260","NCT00374309 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative beta-HCG pregnancy test and the exclusion of women who are breast-feeding or planning to become pregnant during the first 24 weeks after enrollment. Negative beta-HCG pregnancy test (urine or serum) for women presumed to be of reproductive potential. Breast-feeding or planning to become pregnant during the first 24 weeks after enrollment."
"261","NCT02929823 Pregnant individuals are explicitly excluded from the trial as it requires a negative pregnancy test and the use of effective contraception throughout the study. Is a female of childbearing potential with a negative pregnancy test result at Screening and Randomization and agrees to use effective contraception throughout the study, or is a postmenopausal woman with a negative pregnancy test result at Screening and Randomization"
"262","NCT05277350 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must agree to use highly effective contraception for the entire study duration. Pregnancy or lactating or intention of becoming pregnant (all females to agree to use highly effective contraception (defined as those, alone or in combination, that result in a low failure rate i.e., less than 1% per year) for the entire study duration"
"263","NCT04909723 Pregnant individuals are explicitly excluded as participants must not be pregnant and must agree to use highly effective contraceptives. If woman of child-bearing potential, must not be pregnant, and must also agree to use an appropriate highly-effective contraceptive."
"264","NCT04922021 The trial explicitly excludes pregnant or lactating participants. Participant is pregnant or lactating."
"265","NCT03421288 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The inclusion criteria require women of childbearing potential to use contraceptive methods and have a negative pregnancy test before starting the treatment. Pregnancy or breast feeding or planning to become pregnant within 5 months after the end of treatment. Women of childbearing potential must have a negative serum pregnancy test result within 7 days prior to initiation of study treatment."
"266","NCT04649476 Pregnant individuals are explicitly excluded from the trial as female patients must test HCG negative and use contraception. Female patient tested HCG negative in serum or urine within 7 days prior to the start of investigational product. Both patient and partner must agree to use contraception prior to study entry and for the duration of study participation and for up to 120 days after the last dose of PD-1 blockade."
"267","NCT00795262 Pregnant or nursing women are explicitly excluded from the trial. Additionally, women of childbearing potential must use acceptable methods of birth control, and any subject that becomes pregnant during the study will be discontinued. Pregnant or nursing women... any subject that becomes pregnant during the study will be discontinued from the trial."
"268","NCT01321255 Pregnant or premenopausal women are explicitly excluded from the trial. Exclusion Criteria: Pregnant or premenopausal women."
"269","NCT05139238 The study explicitly enrolls postpartum individuals within 6 weeks of delivery and does not include pregnant individuals. The purpose of this study is to assess which blood pressure medication (intravenous labetalol or oral nifedipine) works better in treating severely elevated blood pressure in women who have just delivered a baby."
"270","NCT04662073 Pregnant individuals are explicitly excluded from the trial as participants must yield a negative urine pregnancy test at screening and adhere to contraceptive measures. Participant yields a positive urine pregnancy test at screening."
"271","NCT00803712 Pregnant individuals are explicitly excluded from the trial as indicated by the exclusion criteria requiring a negative pregnancy test and the use of contraceptives. Subject is pregnant (eg, positive HCG test) or is breast-feeding~Refusal to use highly effective contraceptive measures (as determined by the investigator) throughout the study (screening and post enrollment)"
"272","NCT04397458 The study explicitly excludes pregnant individuals as it only includes those who have undergone a cesarean delivery. The intervention is evaluated for its effectiveness in the postpartum period. Inclusion Criteria: elective or non-elective cesarean delivery on prior day"
"273","NCT00208299 Pregnant or breast-feeding individuals are explicitly excluded from the trial. Pregnant or breast-feeding, or (if pre-menopausal), not practicing acceptable method of birth control"
"274","NCT00204230 Pregnant and lactating individuals are explicitly excluded from the trial. Exclusion Criteria: Gravidity or Lactation"
"275","NCT05744687 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women."
"276","NCT00229437 Pregnant and lactating individuals are explicitly excluded from the trial as female subjects of childbearing potential must be nonpregnant, nonlactating, and on an acceptable form of contraception. Female subjects of childbearing potential must be nonpregnant, nonlactating and on an acceptable form of contraception."
"277","NCT02596074 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Pregnant, breast feeding or trying to conceive"
"278","NCT02977286 Pregnant or actively lactating females are explicitly excluded from the trial. Pregnant or actively lactating females"
"279","NCT03757351 The study explicitly excludes women of childbearing potential, indicating that pregnant individuals are not eligible to participate. Women of non-childbearing potential and men, aged 21-80 years"
"280","NCT00240513 Pregnant, breast-feeding, or lactating individuals are explicitly excluded from the trial. Exclusion Criteria:~Pregnancy, breast-feeding or lactating"
"281","NCT02638207 Pregnant and breastfeeding women are explicitly excluded from the trial. Participants must use effective birth control methods. Women who are breast feeding, pregnant, or planning to become pregnant, or are unwilling to use an effective birth control method (such as implants, injectables, combined oral contraceptives, some intrauterine devices (IUDs), sexual abstinence or vasectomized partner) while on study"
"282","NCT00367783 The study explicitly excludes women of childbearing potential, indicating that pregnant individuals are excluded from the trial. Exclusion Criteria: Women of childbearing potential"
"283","NCT00588731 Pregnant and nursing women are explicitly excluded from the trial, and participants must use appropriate birth control measures. Exclusion Criteria: Women who are pregnant, nursing or unwilling to use appropriate birth control measures during study participation."
"284","NCT04615351 The trial explicitly excludes pregnant individuals as it focuses on postpartum females who had gestational diabetes and cannot tolerate metformin. Exclusion Criteria:~Cannot tolerate metformin gestational diabetes"
"285","NCT04970654 The trial is focused on children with growth hormone deficiency and explicitly includes only prepubertal children aged 2-11 years. Pregnant individuals are not mentioned, and the study is clearly not designed for them. Prepubertal children: a) Boys: Age more than or equal to 2 years and 26 weeks and less than or equal to 11.0 years at the time of signing informed consent. b) Girls: Age more than or equal to 2 years and 26 weeks and less than or equal to 10.0 years at the time of signing informed consent."
"286","NCT00414687 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria mention 'Pregnancy, female patients of child-bearing potential without adequate contraception and nursing mothers.' Pregnancy, female patients of child-bearing potential without adequate contraception and nursing mothers."
"287","NCT05828485 Pregnant or lactating women are explicitly excluded from the trial. Additionally, participants must take contraceptives to participate. Pregnant or lactating women; Or having unprotected sex within 2 weeks before using the study drug; Or oral contraceptive use within 30 days or long-acting estrogen or progestin injectable or implant use within 6 months before use of the study drug;"
"288","NCT00236457 Pregnant or nursing females, or those lacking adequate contraception, are explicitly excluded from the trial. Pregnant or nursing females, or those lacking adequate contraception"
"289","NCT00737282 Pregnant or lactating females or women who are attempting or expecting to become pregnant at any time during the study are explicitly excluded. Pregnant or lactating females or women who are attempting or expecting to become pregnant at any time during the study;"
"290","NCT03353753 Pregnant and lactating individuals are explicitly excluded from the trial. Female patients of childbearing potential must have a negative pregnancy test at screening and agree to follow contraception requirements. If female, the patient is pregnant or lactating."
"291","NCT00852696 Pregnant individuals are excluded from the trial as it involves sub-urethral sling procedures and anti-muscarinic medications, which are not suitable for pregnant individuals. Patient is appropriate for sub-urethral sling procedure"
"292","NCT02578472 Pregnant individuals are explicitly excluded from the trial as women of childbearing potential must have a negative pregnancy test and practice a highly effective method of birth control. A woman of childbearing potential must have a negative serum pregnancy test at screening and a negative urine pregnancy test pre-dose on Day 1 of each period."
"293","NCT02404870 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the use of effective contraceptive methods. Positive urine pregnancy test and/or planning to become pregnant during the course of the study. You are unwilling to use effective contraceptive methods for duration of study (hormonal or barrier)."
"294","NCT00788229 Pregnant and lactating individuals are explicitly excluded from the trial. Additionally, females of childbearing potential who are not using systemic contraception, are not postmenopausal, or are not surgically sterilized are also excluded. Exclusion Criteria: Pregnancy or lactation. Females of childbearing potential who are not using systemic contraception, are not postmenopausal (≥ 1 year), or are not surgically sterilized."
"295","NCT03301298 The trial explicitly excludes female subjects of childbearing potential, which includes pregnant individuals. Female subject of childbearing potential."
"296","NCT00802815 Pregnant individuals are explicitly excluded from the trial as women of childbearing potential must have a negative pregnancy test and use adequate birth control. Women of childbearing potential (not postmenopausal or surgically sterile) must have a negative pregnancy test at screening and be using adequate birth control."
"297","NCT05635084 Pregnant or nursing women are explicitly excluded from the trial. Additionally, women of childbearing potential must use highly effective contraception. Pregnant or nursing (lactating) women. Women of childbearing potential, defined as all women physiologically capable of becoming pregnant UNLESS the subject agrees to comply with highly effective, double barrier contraception for the entire duration of the study and for a period of 30 days after the dose of study drug."
"298","NCT00272766 Pregnant individuals are explicitly excluded from the trial as participants must have limited childbearing potential and a negative pregnancy test. Limited child bearing potential and a negative pregnancy test"
"299","NCT04982913 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must take effective contraceptive measures. Female subjects who are not pregnant or lactating and male subjects whose female partners are fertile shall voluntarily take effective contraceptive measures from the date of signing the informed consent form to 3 months after the medication."
"300","NCT01200602 The trial explicitly excludes pregnant individuals as it requires a negative pregnancy test for women of childbearing potential. Negative pregnancy test done =< 7 days prior to registration for women of childbearing potential only"
"301","NCT03621085 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Exclusion Criteria:~Pregnancy or breast feeding"
"302","NCT00790478 Pregnant and breastfeeding women are explicitly excluded from the trial. Female participants must have a negative pregnancy test and practice acceptable contraception. Women who are pregnant, breast-feeding, attempting conception, or planning to attempt conception over the following 6 months, or are currently taking hormone replacement therapy (HRT)."
"303","NCT00250952 Pregnant individuals are explicitly excluded from the trial. The inclusion criteria require a negative pregnancy test and reliable contraception, and the exclusion criteria explicitly exclude pregnant and breastfeeding individuals. Subjects who are pregnant, are planning a pregnancy during the study period, have an infant they are breast feeding, or who are of childbearing potential and not practicing a reliable method of birth control."
"304","NCT01367561 The trial explicitly excludes females, which includes pregnant individuals. Exclusion Criteria: Females"
"305","NCT00861406 Pregnant and lactating women are explicitly excluded from the trial. Women of childbearing potential must have a negative pregnancy test and use contraception. Women of childbearing potential (WOCBP) must not be pregnant (negative urine human chorionic gonadotropin (HCG) within 2 weeks of treatment) or lactating."
"306","NCT00416442 Pregnant individuals are excluded as the study requires female subjects to be surgically sterilized or postmenopausal. Female subjects must have been surgically sterilized at least 6 months prior to screening, with supportive clinical documentation OR Postmenopausal women must have no regular menstrual bleeding for at least 1 year prior to inclusion."
"307","NCT00947791 Pregnant and breastfeeding women are explicitly excluded from the trial. Exclusion Criteria:~Women who plan to become pregnant, are pregnant or are breast-feeding;"
"308","NCT02579603 Pregnant and nursing women are explicitly excluded from the trial. Additionally, women of childbearing potential must use highly effective methods of birth control. Women who are pregnant, nursing, or who plan to become pregnant while in the trial. Women of childbearing potential not willing or able to use highly effective methods of birth control per ICH M3 (R2) that result in a low failure rate of less than 1% per year when used consistently and correctly for 28 days prior to and 3 months after nintedanib administration."
"309","NCT00000451 Pregnant and nursing females are explicitly excluded from the study, and participants must use a reliable method of birth control. Females who are pregnant, nursing, or not using a reliable method of birth control."
"310","NCT00817713 Pregnant and lactating women in the first week of lactation are explicitly excluded from the trial. Exclusion Criteria: Pregnant and lactating women in the first week of lactation"
"311","NCT04360135 The study explicitly excludes pregnant individuals as it involves participants undergoing hysterectomy, which is a surgical procedure to remove the uterus, making pregnancy impossible. Undergoing minimally invasive hysterectomy for benign indications"
"312","NCT00261599 Pregnant and lactating individuals are explicitly excluded from the trial. The inclusion criteria require female patients to be surgically sterile, postmenopausal, or not pregnant or lactating, and to have a negative pregnancy test result at screening and pre-dose. If female, patient must be surgically sterile, postmenopausal, or not pregnant or lactating and must have been using an acceptable method of birth control for at least 1 month prior to dosing, with a negative urine pregnancy test result at screening and pre-dose."
"313","NCT05873062 The study explicitly excludes pregnant individuals as it requires women of childbearing potential to have a negative urine pregnancy test and to comply with contraceptive requirements. Women of childbearing potential must have a negative urine pregnancy test on Visit 2. Willing to comply with contraceptive requirements."
"314","NCT00865215 Pregnant individuals are explicitly excluded from the trial as female volunteers must have a negative pregnancy screen and cannot be currently pregnant or breastfeeding. Female volunteers must have a negative pregnancy screen. Volunteers who demonstrate a positive pregnancy screen (females only). Volunteers who are currently pregnant or breastfeeding (females only)."
"315","NCT03992365 Pregnant, lactating women or women of childbearing potential without an effective method of birth control are explicitly excluded from the trial. Subjects is pregnant, lactating women or women of childbearing potential without an effective method of birth control (e.g. oral contraceptive, intrauterine device, surgical sterilization, hysterectomy)."
"316","NCT04045795 Pregnant individuals are excluded from the trial as indicated by the requirement for contraceptive use by men or women. Male or female: Contraceptive use by men or women"
"317","NCT00956098 Pregnant or lactating individuals are explicitly excluded from the trial. pregnancy or lactation, unwillingness of contraception during the study period"
"318","NCT02542943 Pregnant or breastfeeding women are explicitly excluded from the trial. Exclusion Criteria: Pregnant or breast feeding women"
"319","NCT02044848 Pregnant or lactating individuals are explicitly excluded from the trial. Pregnancy or lactation."
"320","NCT01641939 Pregnant and lactating individuals are explicitly excluded from the trial. For female participants, current pregnancy or lactation"
"321","NCT02981069 Pregnant individuals are explicitly excluded from the trial. The exclusion criteria mention suspected pregnancy, desiring pregnancy in the next 6 months, breastfeeding, or known pregnancy in the last 2 months. Additionally, participants must use two barrier methods of contraception during the study period unless sterilized or have an IUD. Suspected pregnancy (documented negative serum β-hCG test), desiring pregnancy in next 6 months, breastfeeding, or known pregnancy in last 2 months~Patient not willing to use two barrier method contraception during study period (unless sterilized or have an IUD)"
"322","NCT03560349 The study explicitly includes women who have developed a post-dural puncture headache after labor, indicating that participants are postpartum. Pregnant individuals are excluded as the study focuses on the postpartum period. onset of HA within 72 hours of delivery."
"323","NCT02379091 Pregnant or lactating individuals are explicitly excluded from the trial. If female, the participant is pregnant or lactating or intends to become pregnant before, during, or within 18 weeks after the last treatment visit; or intends to donate ova during such time periods."
"324","NCT04530747 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, women of child-bearing potential must agree to use appropriate contraception to avoid pregnancy throughout the study. Exclusion Criteria: Pregnancy, breast feeding or planning pregnancy in the coming 4 months."
"325","NCT02158533 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Are pregnant, planning to become pregnant, or breastfeeding"
"326","NCT00971152 The study explicitly excludes individuals with any contraindication to being pregnant and carrying a pregnancy to term. It focuses on IVF and fertility treatments. Any contraindication to being pregnant and carrying a pregnancy to term"
"327","NCT02519231 Pregnant individuals are explicitly excluded from the trial. The study focuses on new users of the TCu380A IUD and includes criteria that exclude known or suspected pregnancy, as well as postpartum individuals within the past 4 weeks. Exclusion Criteria: Known or suspected pregnancy. Postpartum in the past 4 weeks."
"328","NCT02474069 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, women capable of becoming pregnant must practice a medically approved method of contraception and have a negative pregnancy test before inclusion. Women who are pregnant or breast feeding (pregnancy defined as the state of a female after conception and until the termination of gestation, confirmed by a positive hCG laboratory test (> 5 mIU/ml)) who are menstruating and capable of becoming pregnant* and not practicing a medically approved method of contraception (Pearl Index <1**) during and up to at least 4 weeks after the end of treatment. A negative pregnancy test (serum) for all women and for girls entering menarche is required with sufficient lead time before inclusion"
"329","NCT02058849 Pregnant women are explicitly excluded from the study due to the potential teratogenic or abortifacient effects of chemo-radiation. Additionally, breastfeeding should be discontinued due to potential risks to nursing infants. Pregnant women are excluded from this study because chemo-radiation has the potential for teratogenic or abortifacient effects. Because there is an unknown but potential risk for adverse events in nursing infants secondary to treatment of the mother with chemoradiation, breastfeeding should be discontinued."
"330","NCT01353508 The trial explicitly excludes women of childbearing potential, which includes pregnant individuals. Exclusion Criteria:~Women of childbearing potential"
"331","NCT00797706 The study explicitly excludes pregnant individuals by requiring participants to be clinically sterile females. Inclusion criteria (Run-in period): Caucasian male or clinically sterile female subjects"
"332","NCT00293969 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Exclusion Criteria: pregnancy or breast-feeding"
"333","NCT03976401 The study explicitly excludes pregnant and lactating females as part of the inclusion criteria. Key Inclusion Criteria:~Males and non-pregnant, non-lactating females between 18 - 80 years of age inclusive, based on the date of the screening visit."
"334","NCT00417872 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of childbearing potential must use birth control and have a negative pregnancy test. Females of child bearing age who are either pregnant, breast-feeding or not using birth control. A double barrier method, oral birth control pills administered for at least 2 monthly cycles prior to study drug administration, an IUD, or medroxyprogesterone acetate administered intramuscularly for a minimum of one month prior to study drug administration are acceptable methods of birth control for inclusion into the study. In addition, female patients of child-bearing potential should have a baseline pregnancy test and should agree to continue an acceptable method of birth control for the duration of the study (including follow-up)."
"335","NCT00338455 Pregnant individuals are excluded from the trial as participants must agree to use two highly effective methods of birth control for the duration of the study. male and female subjects of childbearing potential agree to use two highly effective methods of birth control for the duration of the study."
"336","NCT02296190 Pregnant individuals are explicitly excluded from the trial. The inclusion criteria require females of childbearing potential to have a negative pregnancy test and use contraception, and the exclusion criteria state that females who are pregnant or planning to become pregnant during the study period are excluded. Is a female who is breast feeding, pregnant, or planning to become pregnant during the study period"
"337","NCT02263508 Pregnant individuals are explicitly excluded from the trial as participants must not be pregnant or breastfeeding. Subjects must not be pregnant or breastfeeding."
"338","NCT04105270 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The exclusion criteria state that participants must not be pregnant or breastfeeding and must provide evidence of post-menopausal status or a negative pregnancy test. Not pregnant or breast feeding. Evidence of post-menopausal status, or negative urine or serum pregnancy test for female pre-menopausal patients."
"339","NCT02330146 Pregnant and nursing women are explicitly excluded from the trial. Additionally, women of childbearing potential must use highly-effective methods of birth control during the study. Women who are pregnant or nursing"
"340","NCT01537432 Pregnant or nursing (lactating) women are explicitly excluded from the trial. Pregnant or nursing (lactating) women"
"341","NCT00274261 The study explicitly excludes pregnant individuals as participants must have a negative urine pregnancy test prior to enrollment and must not be pregnant or have a suspected pregnancy during the course of the study. Additionally, participants must be willing to accept a risk of pregnancy and use the study product as the primary method of contraception. Have a negative urine pregnancy test prior to enrollment. Be pregnant, have a suspected pregnancy or desire to become pregnant during the course of the study."
"342","NCT02139644 Pregnant and lactating individuals are explicitly excluded from the trial. The exclusion criteria state that female patients may not be pregnant, breastfeeding, or attempting to become pregnant. Female patients may not be pregnant, breastfeeding, or attempting to become pregnant."
"343","NCT00964665 Pregnant individuals are explicitly excluded as participants must be of non-childbearing potential or use two forms of birth control. Inclusion Criteria: Male or female, aged 18-75 years of either non-child bearing potential or if of child bearing potential on two adequate forms of birth control"
"344","NCT03485157 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Subject is pregnant or plans to become pregnant within 365 days of treatment"
"345","NCT05952557 Pregnant individuals are explicitly excluded from the trial as participants must not be currently pregnant or breastfeeding. Currently pregnant (confirmed with positive serum pregnancy test) or breastfeeding."
"346","NCT00511342 The trial explicitly excludes pregnant and breastfeeding individuals, as well as those within 12 months after a pregnancy or stopping breastfeeding. The study focuses on evaluating the effects of a combined oral contraceptive on bone mineral density in healthy young women. Within 12 months after a pregnancy prior to the start of trial medication; Breastfeeding or within 12 months after stopping breastfeeding prior to the start of trial medication."
"347","NCT06124573 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the exclusion of those who are pregnant or likely to become pregnant during the study. Female subject, who is currently breast feeding or a who is pregnant or who is likely to become pregnant during the study. Female subject has a positive pregnancy test result."
"348","NCT05171179 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Subjects who are pregnant at the date of surgery."
"349","NCT00235495 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Women of childbearing age must have a negative pregnancy test prior to ALB administration. Pregnancy, breastfeeding or positive pregnancy test. (Women of childbearing age must have a negative pregnancy test prior to ALB administration.)"
"350","NCT02074267 Pregnant, lactating individuals, or those of childbearing potential not using effective contraceptives are explicitly excluded from the trial. Subjects who are pregnant, lactating or of childbearing potential not using effective contraceptives."
"351","NCT00084318 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and use effective contraception during and for 3 months after study participation. Not pregnant or nursing~Negative pregnancy test~Fertile patients must use effective contraception during and for 3 months after study participation"
"352","NCT05581758 The study explicitly excludes females of childbearing potential, indicating that pregnant individuals are not included. Females of nonchildbearing potential."
"353","NCT01803711 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Pregnant patients, breastfeeding or those planning to become pregnant during the study."
"354","NCT04665115 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Female subjects who are pregnant, or breastfeeding, or planning to become pregnant while enrolled in this study or within 1 month of last dose of study drug."
"355","NCT01989455 The trial explicitly excludes pregnant individuals as it requires a negative result on a serum pregnancy test for female participants. For females, negative result on a serum pregnancy test."
"356","NCT02972502 Pregnant and breastfeeding women are explicitly excluded from the trial. Exclusion Criteria:~Known pregnancy~Breast-feeding women"
"357","NCT03508440 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnancy"
"358","NCT00350168 Pregnant or nursing women are explicitly excluded from the trial. Additionally, women of child-bearing potential must use acceptable methods of contraception. Pregnant or nursing (lactating) women"
"359","NCT04020718 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant, planning to become pregnant in the next 3 months, or breastfeeding."
"360","NCT00442897 Pregnant women are explicitly excluded from the trial. Exclusion Criteria:~Pregnant women"
"361","NCT00412074 The study explicitly excludes pregnant individuals as it focuses on lactating mothers and their infants. The inclusion criteria specify that the mother must plan to breastfeed exclusively for at least six months, indicating that the study is for postpartum individuals. Mother plans to breastfeed exclusively for at least six months"
"362","NCT00468936 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria:~Pregnancy heart transplant patients"
"363","NCT05461131 Pregnant individuals are explicitly excluded from the trial as participants must not reside in the same home, work regularly with, or have contact with pregnant women. Resides in the same home, works regularly with, or has contact (face to face <2 meters), with infants less than 1 year of age, partially immunised infants or pregnant women, adults >65 years of age who have not received a dose of acellular pertussis vaccine (e.g. Tdap) within the past 10 years from study vaccination to challenge and for 1 week after exiting the challenge unit"
"364","NCT03971383 Pregnant or lactating women are explicitly excluded from the trial. Pregnant or lactating women or those who are planning to conceive during the study period;"
"365","NCT01888003 Pregnant or lactating individuals are explicitly excluded from the trial. Pregnancy or lactation"
"366","NCT02843386 Pregnant and/or breastfeeding women are explicitly excluded from the trial. Pregnant and/or breastfeeding women."
"367","NCT00493636 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, women of childbearing potential must have a negative serum pregnancy test and agree to use contraception. Women of childbearing potential must have a negative serum pregnancy test performed within 7 days prior to randomization, and must agree to use adequate contraception prior to study entry, for the duration of study participation and 28 days after the last study drug dosing. Women who are pregnant or breast-feeding."
"368","NCT02864082 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. The study does not focus on nonviable pregnancies or postpartum interventions. Patient is pregnant or breast feeding, or is planning to become pregnant during the study."
"369","NCT00437684 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Subject is pregnant or wishes to become so"
"370","NCT00586482 Pregnant or lactating females are explicitly excluded from the trial. Females who are pregnant or lactating"
"371","NCT06179888 Pregnant individuals are explicitly excluded from the trial due to the potential genotoxic, mutagenic, and teratogenic effects of the investigational agent iberdomide. The study requires females of childbearing potential to use contraception and have a negative pregnancy test before starting the treatment. Not pregnant and not nursing, because this study involves an investigational agent whose genotoxic, mutagenic and teratogenic effect on the developing fetus and newborn are unknown."
"372","NCT04372121 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The study focuses on women with endometriosis-associated pain and requires participants to not plan a pregnancy during the study. The subject will be excluded if she: is pregnant or breast feeding or is planning a pregnancy within the duration of the of the study (including the Follow-up Period)"
"373","NCT00489528 Pregnant and breastfeeding women are explicitly excluded from the trial. If female, be neither pregnant or breast feeding."
"374","NCT00490113 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria:~Pregnancy"
"375","NCT01366001 Pregnant and lactating individuals are explicitly excluded from the trial. If female, be currently pregnant or lactating or planning to become pregnant within 60 days of last study drug administration."
"376","NCT01542372 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant"
"377","NCT01240187 The study explicitly excludes pregnant women by requiring women to use two methods of contraception. Women who do not agree to use two methods of contraception."
"378","NCT00487994 Pregnant individuals are excluded from the trial as females of child-bearing age must have undergone surgical sterilization, hysterectomy, tubal ligation, or bilateral oophorectomy. Females of child-bearing age must have undergone surgical sterilization, hysterectomy, tubal ligation, or bilateral oophorectomy; other female subjects must have been postmenopausal."
"379","NCT05839639 Pregnant and lactating individuals are explicitly excluded from the trial. Females who are pregnant or lactating at screening;"
"380","NCT01729494 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the use of reliable contraception. Female patients of child bearing potential must have a negative urine or serum pregnancy test within the past 48 hours prior to study inclusion. Patient is pregnant, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by positive human Chorionic Gonadotropin (hCG) laboratory test. Women of childbearing potential must use reliable contraception simultaneously, unless they are status post bilateral tubal ligation, bilateral oophorectomy, or hysterectomy."
"381","NCT05001854 Pregnant or nursing women are explicitly excluded from the trial. Pregnant or nursing woman"
"382","NCT06019936 Pregnant and lactating individuals are explicitly excluded from the trial. Participants must have a negative pregnancy test or use effective contraceptive methods. Patients are under the gestation, lactation, or patients have the pregnancy planning during the study period and 90 days after the end of the clinical trial"
"383","NCT04534153 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Participants must also practice birth control during the study. Subjects who are pregnant, breastfeeding, or unwilling to practice birth control during participation in the study."
"384","NCT01827384 Pregnant and breastfeeding women are explicitly excluded from the trial. The study requires the use of highly effective contraception for women of childbearing potential and men, and breastfeeding must be discontinued during the trial and for 30 days after the last dose of the study drug. Women who are pregnant or breastfeeding"
"385","NCT04515576 Pregnant individuals are excluded as the study only includes males and females not of childbearing potential. Are male or female not of childbearing potential"
"386","NCT01976988 Pregnant patients are explicitly excluded from the trial. Exclusion Criteria: Pregnant patients"
"387","NCT02239770 Pregnant and nursing women are explicitly excluded from the trial. Participants must use medically acceptable forms of birth control if they are trying to become pregnant. Women who are pregnant (verified by urine pregnancy test at visit), trying to become pregnant (not using a medically acceptable form of birth control for at least one month prior to visit i.e., oral contraceptives, intrauterine device, double barrier), or nursing."
"388","NCT00446134 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test and the exclusion of breastfeeding females. Female patients who are breast-feeding or have a positive pregnancy test at any time during the study"
"389","NCT00747214 Pregnant and lactating individuals were explicitly excluded from the trial. Additionally, females of childbearing potential not using acceptable methods of birth control were also excluded. Female subject is pregnant or lactating or of child bearing potential not using acceptable methods of birth control (barriers or abstinence). Female subjects using hormonal birth control are not to be enrolled."
"390","NCT05301530 The trial explicitly excludes pregnant and lactating individuals, as well as those intending to get pregnant. Pregnancy, intend to get pregnant, lactation"
"391","NCT02155634 Pregnant or lactating females are explicitly excluded from the trial. Additionally, females of childbearing potential must have two negative pregnancy tests and agree to ongoing pregnancy testing and effective contraception. Pregnant or lactating females."
"392","NCT01248494 The trial explicitly includes only postmenopausal patients, which excludes pregnant individuals. The inclusion criteria specify that participants must be postmenopausal, and there is no mention of pregnancy or lactation in the inclusion or exclusion criteria. Post-menopausal female subjects should be defined prior to protocol enrollment by any of the following: Subjects at least 55 years of age; Subjects under 55 years of age and amenorrheic for at least 12 months or follicle-stimulating hormone (FSH) values >/= 40 IU/L and estradiol levels </= 20 IU/L; Prior bilateral oophorectomy; Prior radiation castration with amenorrhea for at least 6 months; Current use of an LHRH agonist for more than 12 months."
"393","NCT04497987 Pregnant individuals are explicitly excluded as the inclusion criteria specify 'non-pregnant women who agree to contraceptive requirements'. Are men or non-pregnant women who agree to contraceptive requirements"
"394","NCT00960141 Pregnant individuals are excluded as the study explicitly excludes women who are less than 8 weeks postpartum or breastfeeding. Patient is a woman who is <8 weeks postpartum or is breast feeding"
"395","NCT01949051 Pregnant individuals are explicitly excluded from the trial as it requires a negative pregnancy test and the use of contraception. A female subject is eligible to participate if she is of: Non-childbearing potential defined as pre-menopausal females with a documented tubal ligation or hysterectomy...; child-bearing potential with negative pregnancy test as determined by urine human chorionic gonadotropin (hCG) test at screening or prior to dosing and agrees to use one of the contraception methods..."
"396","NCT00869206 Pregnant and nursing individuals are explicitly excluded from the trial. Not pregnant and not nursing"
"397","NCT00982566 Pregnant and breastfeeding women are explicitly excluded from the trial. Female subjects must be surgically sterile, postmenopausal, or have negative pregnancy test results. Non-surgically sterile or non-postmenopausal women must use birth control methods. Female subject is pregnant or breast-feeding."
"398","NCT02130804 Pregnant and lactating women are explicitly excluded from the trial as indicated by the exclusion criteria requiring a negative pregnancy test and excluding current lactation. A positive pregnancy test or current lactation"
"399","NCT01725100 The trial explicitly excludes pregnant and lactating women as participants must have a negative pregnancy test and agree to use effective contraception. Additionally, lactating or actively breastfeeding women are excluded. Women of childbearing potential must have a negative serum pregnancy test within 14 days of first dose of study treatment and agree to use effective contraception, during the study and for 4 months following the last dose of study treatment. Female Subjects: Lactating or actively breastfeeding."
"400","NCT03673605 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria:~Pregnancy"
"401","NCT00372216 Pregnant or nursing (lactating) women and women with childbearing potential are explicitly excluded from the trial. Pregnant or nursing (lactating) women~Women with childbearing potential"
"402","NCT01721694 Pregnant or lactating women are explicitly excluded from the trial. Women of childbearing age may participate if they use contraception and have a negative urine pregnancy test. Pregnant or lactating. (Women of childbearing age may be admitted if they use contraception and submit urine pregnancy test negative)"
"403","NCT06023459 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Be currently pregnant or breastfeeding or planning on conception"
"404","NCT01225640 Pregnant or nursing females are explicitly excluded from the trial. Females of childbearing potential must adhere to contraception guidelines. Pregnant or nursing females; females of childbearing potential unwilling or unable to adhere to contraception guidelines."
"405","NCT05891886 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Known pregnancy"
"406","NCT02914353 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative pregnancy test at screening or check-in. Positive pregnancy test at screening or check-in (Day -1)."
"407","NCT01289782 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant or planning to become pregnant"
"408","NCT00984152 The trial explicitly excludes pregnant individuals by requiring a negative pregnancy test and the use of contraception for women of reproductive potential. Negative serum or urine pregnancy test within 48 hours prior to initiating study medications unless otherwise specified by product labeling. Contraception requirements for women who have not undergone surgical sterilization."
"409","NCT01423032 Pregnant individuals are explicitly excluded from the trial as it requires a negative pregnancy test or adequate contraception. negative pregnancy test/ adequate method of contraception"
"410","NCT00759551 The study explicitly excludes pregnant and lactating women by requiring female patients of childbearing potential to be nonpregnant and nonlactating, and to utilize an acceptable method of contraception. Female patients of childbearing potential must be nonpregnant and nonlactating, and utilizing an acceptable method of contraception."
"411","NCT02932020 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Patient is pregnant"
"412","NCT00905606 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for a negative urine pregnancy test at screening and the inclusion of only post-menopausal or surgically sterilized females. Additional exclusion criteria for females only: Positive urine pregnancy test at screening (performed on all females)."
"413","NCT03848793 Pregnant individuals are explicitly excluded from the trial as the exclusion criteria state that female subjects of childbearing potential who do not use an acceptable method of birth control, are pregnant, planning a pregnancy, or breastfeeding are not eligible. Female subject of childbearing potential who does not use an acceptable method of birth control, is pregnant or planning a pregnancy, or breastfeeding"
"414","NCT01945775 Pregnant individuals are excluded from the trial as the exclusion criteria require participants to not be candidates for certain treatments, which typically includes pregnancy considerations. Exclusion Criteria: Cytotoxic chemotherapy within 14 days before randomization"
"415","NCT00835640 Pregnant individuals are explicitly excluded from the trial as female volunteers must demonstrate a negative pregnancy screen and practice acceptable birth control methods. Female volunteers who are demonstrating a positive pregnancy screen."
"416","NCT00596206 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, women of childbearing potential must fulfill specific conditions to participate. Exclusion Criteria: Pregnancy, Breastfeeding, Women of childbearing potential, except if they fulfill specific conditions."
"417","NCT01449799 Pregnant and lactating females are explicitly excluded from the trial. The inclusion criteria require female subjects of childbearing potential to use contraception, and the exclusion criteria specify that pregnant females as determined by a positive serum hCG test and lactating females are not eligible. Pregnant females as determined by positive serum Human Chorionic Gonadotrophin (hCG test) at screening or prior to dosing. Lactating females."
"418","NCT00805415 The study investigates ovulation inhibition with oral contraceptive regimens, explicitly excluding pregnant individuals by requiring non-hormonal methods of contraception. Healthy women willing to use non-hormonal methods of contraception"
"419","NCT00829790 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Female participants must use contraception if sexually active and must have a negative pregnancy test result. Subject must be male or non-pregnant, non-breast-feeding female; Is a female with a positive pregnancy test result."
"420","NCT05501327 Pregnant and breastfeeding women are explicitly excluded from the trial. The study does not focus on nonviable pregnancies or postpartum interventions. Female subjects who are pregnant, breast-feeding, or of childbearing potential and not practicing reliable birth control methods"
"421","NCT05295121 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, a positive urine pregnancy test is listed as an exclusion criterion. Pregnancy, breastfeeding, positive urine pregnancy test (for women of preserved reproductive potential)."
"422","NCT02284256 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test and agree to use contraception. If female and of child-bearing potential, subject has negative pregnancy test during screening and is not breast-feeding"
"423","NCT00583154 Pregnant and lactating individuals are explicitly excluded from the trial. Additionally, participants must use acceptable forms of birth control and have a negative pregnancy test at screening. Subjects who are pregnant or lactating, or intending to become pregnant during the study"
"424","NCT03335488 Pregnant or breast-feeding patients are explicitly excluded from the trial. Women of childbearing potential must have a pregnancy test performed at the Baseline Visit prior to the start of study drug. Pregnant or breast-feeding patients. Women of childbearing potential must have a pregnancy test performed at the Baseline Visit prior to the start of study drug."
"425","NCT04182997 Pregnant individuals are explicitly excluded from the trial as indicated by the requirement for qualitative human chorionic gonadotropin (hCG) testing prior to enrollment. Pregnancy - qualitative human chorionic gonadotropin (hCG) testing will be performed prior to enrollment"
"426","NCT03446612 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of childbearing potential must use contraception. A female participant is eligible to participate if she is not pregnant, not breastfeeding, and at least one of the following conditions applies: Not a woman of childbearing potential (WOCBP) or a WOCBP who has been on an approved form of contraceptive for the 4 weeks prior to Day 1 and agrees to follow the contraceptive guidance until the Follow-up visit."
"427","NCT04235322 Pregnant or breastfeeding women are explicitly excluded from the trial. Additionally, women of childbearing age must be under effective contraception. Exclusion Criteria: Pregnant or breastfeeding woman, Woman of childbearing age under effective contraception"
"428","NCT01480310 Pregnant or lactating women are explicitly excluded from the trial. Female subjects must use two effective methods of contraception. Exclusion Criteria: Pregnant or lactating women"
"429","NCT01885559 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant/intention to become pregnant in 4-6 yrs."
"430","NCT05174065 Pregnant individuals are explicitly excluded from the trial as female participants of childbearing potential with a positive pregnancy test are not allowed to participate. Female participants of childbearing potential with a positive pregnancy test"
"431","NCT02896101 Pregnant and lactating individuals are explicitly excluded from the trial. Inclusion Criteria: Male or non-pregnant, non-lactating female subjects 12 years of age and older."
"432","NCT01955616 Pregnant and lactating individuals are explicitly excluded from the trial. Female participants must have a negative pregnancy test and use contraception. Female patients must have negative serum or urine pregnancy tests and must not be lactating. For females able to bear children, a hormonal (i.e., oral, implantable, or injectable) and single-barrier method, or a double-barrier method of birth control must be used throughout the study."
"433","NCT03279081 Pregnant or breastfeeding women are explicitly excluded from the trial. Additionally, women of childbearing potential must have a negative pregnancy test and use contraception. Pregnant or breastfeeding women. Women of childbearing potential (WCBP) must have negative serum pregnancy test at screening (sensitive to 25 international units [IU] human chorionic gonadotropin [hCG]). Both WCBP or male participants participating in this study, with a WCBP as partner, must agree to use an adequate method of contraception during the entire duration of the study."
"434","NCT00543647 Pregnant and breastfeeding women are explicitly excluded from the trial. Additionally, women of childbearing potential must use a reliable method of contraception. Pregnant, breast-feeding, or woman with child bearing potential without a reliable method of contraception."
"435","NCT05334485 Pregnant or breastfeeding females are explicitly excluded from the trial due to the potential teratogenic or abortifacient effects of pyridostigmine. Pregnant or breastfeeding females as PYR is classified by the FDA as a pregnancy risk category C medication with the potential for teratogenic or abortifacient effects and demonstrated secretion into breastmilk with an unknown but potential risk for adverse effects in the nursing infants"
"436","NCT04934475 The trial explicitly excludes pregnant and breastfeeding women, and requires women of childbearing potential to have a negative pregnancy test and use contraception. Women of childbearing potential must have a negative serum or urine pregnancy test within 10 to 14 days prior to therapy and repeated within 24 hours before starting study drug. They must commit to continued abstinence from heterosexual intercourse or begin 2 acceptable methods of birth control (One highly effective method and one additional effective method) used at the same time, beginning at least 4 weeks before initiation of Lenalidomide treatment and continuing for at least 30 days after the last dose of Lenalidomide, Iberdomide and 5 months after last dose of Isatuximab. Women must also agree to notify pregnancy during the study. Female subject who is pregnant or breast-feeding."
"437","NCT00882635 Pregnant and lactating individuals are explicitly excluded from the trial. The exclusion criteria state that pregnancy, lactation, or parturition within the previous 30 days are grounds for exclusion. Additionally, women of childbearing potential must be using a medically accepted method of birth control. Pregnancy or lactation or parturition within the previous 30 days; women of childbearing potential must be using a medically accepted method of birth control"
"438","NCT01565018 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Subject is pregnant or nursing healthy volunteers"
"439","NCT00568074 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Participants must use adequate contraceptive measures. Exclusion Criteria: Pregnancy, breast-feeding, the intention of becoming pregnant or judged to be using inadequate contraceptive measures (adequate contraceptive measures are: sterilisation, intra-uterine device (IUD), oral contraceptives or barrier methods)"
"440","NCT03131336 Pregnant or breast-feeding subjects are explicitly excluded from the trial. Pregnant or breast-feeding subject."
"441","NCT00577161 Pregnant or lactating women are explicitly excluded from the trial. Additionally, potentially fertile men and women and their sexual partners must use adequate contraception during the study and for 6 months after the last day of study drug administration. Pregnant or lactating women~Potentially fertile men and women and their sexual partners not willing to use adequate contraception as defined by the Investigator during the study and for 6 months after the last day of study drug administration"
"442","NCT01082081 The study explicitly excludes pregnant individuals by requiring participants to be aged 18-45 years and does not mention pregnancy in the inclusion criteria. Subjects aged 18-45 years with moderate-to-severe dental pain assessed by verbal rating scale (VRS) and confirmed by a score of at least 50 mm out of 100 mm using a visual analogue scale (VAS) following surgical removal of third molars, of which at least one has to be a mandibular partially bony or full bony impaction."
"443","NCT01085630 Pregnant and nursing women are explicitly excluded from the trial. Participants must use effective contraception and have a negative pregnancy test. Non-pregnant and non-nursing; women of child bearing potential and men must agree to use an appropriate method of birth control throughout their participation in this study; appropriate methods of birth control include abstinence, oral contraceptives, implantable hormonal contraceptives (Norplant), or double barrier methods (diaphragm plus condom)"
"444","NCT00404547 Pregnant and breastfeeding individuals are explicitly excluded from the trial. The study also excludes those intending to become pregnant or lacking safe contraception. Pregnancy, breast feeding, intention to become pregnant during the course of the study or lack of safe contraception in pre-menopausal women"
"445","NCT00904085 Pregnant individuals are explicitly excluded from the trial as participants must have a negative pregnancy test. Have a positive pregnancy test"
"446","NCT00568061 Pregnant and lactating women, as well as women of childbearing potential, are explicitly excluded from the trial. Pregnancy, lactating, and women of childbearing potential."
"447","NCT00491504 Pregnant individuals are explicitly excluded from the trial as participants must use contraception and have negative pregnancy tests during the study. Women must practice adequate contraception: Females of childbearing potential (including women who are less than 1 year postmenopausal and women who will be sexually active during the study) must agree to use a medically accepted method of contraception or be surgically sterilized prior to screening, while receiving protocol-specified medication, and for 30 days after stopping the medication. Negative pregnancy tests during study."
"448","NCT06090539 Pregnant individuals are explicitly excluded from the trial as participants must accept and follow a pregnancy prevention plan. Participants must accept and follow pregnancy prevention plan."
"449","NCT03382717 Pregnant and nursing women are explicitly excluded from the trial. Female subjects of childbearing potential are required to use contraceptives. Woman being pregnant, nursing or planning a pregnancy during the course of this study."
"450","NCT04853134 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Not Pregnant or breastfeeding"
"451","NCT00400179 Pregnant or lactating females are explicitly excluded from the trial. Is a pregnant or lactating female"
"452","NCT01523184 Pregnant individuals are explicitly excluded from the trial as females of childbearing potential must complete a negative pregnancy test prior to receiving any radioisotopes. Females of childbearing potential (ie, not menopausal, no hysterectomy, no bilateral oophorectomy) must complete a negative pregnancy test (urine) prior to receiving any radioisotopes"
"453","NCT01221246 Pregnant and breastfeeding women are explicitly excluded from the trial. The exclusion criteria state that women of childbearing potential who are pregnant or breastfeeding or unable to practice birth control during the study period are not eligible. Women of child bearing potential who are pregnant or breast-feeding or unable to practice birth control during the study period"
"454","NCT00840216 Pregnant and lactating females are explicitly excluded from the study. Female subjects must have a negative pregnancy test prior to each study period check-in. Females who are pregnant or lactating."
"455","NCT05359653 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Additionally, women must use appropriate contraception during the trial. Pregnancy, breastfeeding or planning to become pregnant."
"456","NCT04913610 Pregnant and breastfeeding women are explicitly excluded from the trial. Women of child-bearing potential must use a highly effective form of birth control. For women of child-bearing potential: pregnant, based on date of last menstrual period, and pregnancy test prior to first intake of IMP, or breastfeeding."
"457","NCT01011452 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Additionally, those intending pregnancy or unable to take adequate precautions against conception are also excluded. Exclusion Criteria: Pregnancy or breastfeeding. Intended pregnancy or inability to take adequate precautions against conception."
"458","NCT05509257 The study explicitly excludes pregnant individuals as indicated by the exclusion criteria requiring a negative pregnancy test. Exclusion Criteria: Pregnant (via UCG)"
"459","NCT02921256 Pregnant women are explicitly excluded from the trial. The exclusion criteria state that pregnant women and nursing women who are unwilling to discontinue nursing are not eligible. Additionally, men or women of childbearing potential must employ adequate contraception. Any of the following because this study involves agents that have known or potential genotoxic or mutagenic, and teratogenic effects:~Pregnant women~Nursing women who are unwilling to discontinue nursing~Men or women of childbearing potential who are unwilling to employ adequate contraception (e.g., hormonal or barrier method of birth control; abstinence) for the duration of study treatment and for 4 months after the last dose of study therapy"
"460","NCT00279916 Pregnant individuals are explicitly excluded from the trial as per the exclusion criteria. Exclusion Criteria: Unwilling to discontinue breast feeding, when applicable"
"461","NCT01535014 Pregnant and breastfeeding individuals are explicitly excluded from the trial. Participants must comply with contraception methods during the trial and within 30 days after completion. Pregnancy, breast-feeding, unwillingness to comply with contraception methods during the trial and within 30 days after completion of participation in the trial."
"462","NCT02893176 Pregnant individuals are explicitly excluded from the trial as females of childbearing age must implement appropriate contraception and undergo mandatory monthly pregnancy tests. Females of child bearing age who could become pregnant, must implement appropriate contraception per FDA requirement for ERA medical treatment with mandatory MONTHLY monitoring of urine or serum pregnancy tests."
"463","NCT01705288 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: Pregnant"
"464","NCT01346774 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria:~Pregnancy"
"465","NCT02436707 Pregnant or lactating females are explicitly excluded from the study. Additionally, women of childbearing potential must use contraception and have a negative pregnancy test before participation. Women of childbearing potential must have a pregnancy test taken (either by serum beta-human chorionic gonadotropin [B-hCG]) or urine) and proven negative within 14 days prior to randomization. Women who are pregnant or breastfeeding are ineligible for this study."
"466","NCT01751386 Pregnant or breastfeeding women are explicitly excluded from the trial. Participants must use effective birth control and have a negative pregnancy test at each visit. Pregnancy or breast feeding women or not using an adequate form of birth control"
"467","NCT01313624 Pregnant and breastfeeding individuals were explicitly excluded from the trial. Exclusion Criteria:~Pregnant, breastfeeding, or unwilling to follow contraceptive measures for the study"
"468","NCT02877979 The trial explicitly excludes pregnant and breastfeeding women, and requires participants to be on a stable form of contraception. Currently pregnant or had their last pregnancy outcome within 3 months prior to screening~Currently breast-feeding~On a stable form of contraception"
"469","NCT01104766 Pregnant and breastfeeding women are explicitly excluded from the trial. Women who are pregnant or breast feeding"
"470","NCT03571334 Pregnant and breastfeeding women are explicitly excluded from the trial. The study focuses on the treatment of chemotherapy-induced peripheral neuropathy in breast cancer patients. Female participants who are pregnant (positive urine pregnancy test), who have an infant they are breastfeeding, or intend to become pregnant within 6 months."
"471","NCT01752023 Pregnant women are explicitly excluded from this study due to the potential teratogenic or abortifacient effects of the drugs used. Pregnant women are excluded from this study because itraconazole is Class C agent and both gemcitabine and cisplatin are Class D agents, with the potential for teratogenic or abortifacient effects."
"472","NCT01090492 Pregnant or breastfeeding individuals are explicitly excluded from the trial. Pregnant or breast feeding or considering pregnancy in next 4 months"
"473","NCT04524026 The study is focused on ovarian stimulation and luteal support in IVF, explicitly excluding pregnant individuals as it involves oocyte donors and requires participants to meet specific criteria related to ovarian stimulation. Exclusion Criteria: Contraindications for ovarian stimulation or aspiration of oocytes according to local guidelines"
"474","NCT03268278 Pregnant individuals are explicitly excluded from the trial as stated in the exclusion criteria. Exclusion Criteria: pregnancy"
"475","NCT03687827 Pregnant and breastfeeding women are explicitly excluded from the trial. Women cannot take part if pregnant, breast-feeding or plan to become pregnant during the study period."
"476","NCT00463346 Pregnant and nursing women are explicitly excluded from the trial. Additionally, women of childbearing potential who are sexually active and do not use adequate contraception are also excluded. Women who are pregnant or nursing, or women of childbearing potential who are sexually active and who do not use adequate contraception, or who are judged to be unreliable in their use of contraception."
